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PRE· FA C E 
The experimental work described in this thesis was carried out in the 
Department of Chemical Pathology, University of Natal Medical School, 
Durban. 
These studies represent original work by the author and have not been 
submitted to any other university. Where use was made of the work of 
others, it has been duly acknowledged in the text. 
The following is a publication from this work: 
DUNN R, JIALAL I, PUDIFIN D, JOUBERT SM (1986). Demonstration of insulin 
receptors on cultured lymphocytes of the Raji cell line. South African 
Journal of Science 82: 436-437. 
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INTRODUCTION 
The notion that insulin binds to a specific site on the cell mem-
brane was first proposed many years ago. However, experimental proof 
of a membrane bound insulin receptor did not come until the early 
1970s when biologically active radiolabelled insulin was used in 
direct binding studies (Cuatrecasas, 1971). 
Recent advances in understanding the mechanism of insulin action are 
the result of studies on the structure and function of the insulin 
receptor. The membrane receptor would appear to have two functions: 
firstly, it must bind insulin and secondly, it must couple insulin 
binding to insulin action. Defects in either of these receptor func-
tions will result in an impaired response to insulin, or insulin 
resistance (Taylor, 1985). 
Insulin resistance is a common disorder in a number of disease 
states in man. For example, non-insulin-dependent diabetes mellitus 
and obesity are associated with mild insulin resistance (Bar et aZ., 
1976). There are also a number of relatively rare syndromes of ex-
treme insulin resistance in which there is either impaired receptor 
function, or an immunological defect resulting in the development of 
auto-antibodies against the insulin receptor (Taylor et aZ., 1985). 
Studies on insulin receptor defects associated with these disease 
states have led to progress in understanding the molecular mecha-
nisms of insulin action. 
Ideally when investigating these disease states one should study 
insulin action on classical target cells such as adipocytes, hepato-
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cytes or muscle. However, it is now well established that the kine-
tics of insulin binding to its membrane receptor is similar in all 
human tissue whether or not it is a target for insulin action. This 
has led to a great deal of research on the more accessible human 
tissues such as monocytes, erythrocytes, cultured fibroblasts and 
Epstein-Barr virus (EBV) transformed B-Iymphocytes. The most conve-
nient tissue to study is EBV transformed B-Iymphocytes, as these 
cells can be taken from individual patients and grown in culture in 
large quantities, which facilitates biochemical studies. Despite 
these advantages, it is important to establish that this virus-indu-
ced receptor is a true insulin receptor and not an artifact of viral 
transformation. 
Studies on B-Iymphocyte proliferation have shown that the insulin 
receptor appears on the cell membrane during the proliferative phase 
of B-cell activation. However , this is a transient event and once 
the cell reaches maturation the insulin receptor is no longer evi-
dent (Marchalonis & Galbraith, 1987). The insulin receptor has also 
been demonstrated in a number of cultured human lymphoblastoid cell 
lines (Gavin et aL, 1983; Maegawa et aL, 1983). It seems, there-
fore, that the insulin receptor is normally expressed by blast cells. 
The purpose of this study was to investigate insulin binding charac-
teristics on a human lymphoblastoid cell line with B-cell character-
istics which was originally derived from a patient with Burkitt's 
lymphoma. These cells, which are known as Raji cells, are unusual in 
that they carry multiple copies of the EBV genome in their DNA. For 
this reason they provide a useful model system for studying the 
vii i 
insulin receptor in EBV transformed lymphocytes. In addition, stu-
dies on the mechanism of insulin action in these cells should give 
some insight into the function of the insulin receptor during B-cell 
proliferation. 
In this study four major characteristics of insulin binding to insu-
lin receptors on Raji cells are described. 
Firstly, on the basis of kinetic studies a model for insulin-recep-
tor interaction was established. 
Secondly, processing of insulin and the receptor was investigated to 
determine whether the receptor is functional. 
A third aspect was elucidation of the receptor structure and the 
insulin binding site. 
Finally, the cross-reaction between insulin and type I IGF receptors 
was studied, and the cellular response mediated by the insulin re-
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A LITERATURE REVIEW OF INSULIN RECEPTORS 
"RegardLess of whether or not intact ceLLuLar morphoLogy 
is an obLigatory requirement for insuLin action, the first 
step in the action of insuLin in ceLLuLar systems must be 
its entrance into, or attachment to, some morphoLogicaL 
eLement of the intact ceLL /I 
-STADIE et aL. 1949 
1.1 HISTORICAL REVIEW 
Evidence that insulin acts on tissue membranes became available in 
the late 1940s and early 1950s. 
In the first of these experiments Stadie et aL. (1949), on the basis 
of studies on insulin action on rat hemidiaphragms, suggested that 
insulin became bound to tissue membrane. Shortly afterwards work by 
Levine et aL. (1950) on galactose transport in dogs and rats, sug-
gested a rapid membrane action of insulin. However, for several rea-
sons these studies were slow to develop. Firstly, because of the low 
concentration of circulating hormone, the amount bound to the cell 
was low and, therefore, difficult to measure. Secondly, measuring 
the uptake of an unlabelled hormone by following its disappearance 
from the incubation medium was complicated by the difficulty in dis-
tinguishing hormone binding from hormone degradation. These diffi-
culties prompted the use of radioactively-labelled hormone. 
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In 1953 Stadie et a'l. introduced the use of (35 SJinsul in sulphate and 
131I-insulin to directly study the interaction of insulin with rat 
diaphragm. These studies however, were criticised by Newerly and 
Berson (1957) who pOinted out the lack of "specificity" of 131I-insu-
lin binding to diaphragm and the altered biological activity of the 
labelled hormone. Direct binding studies using radiolabelled insulin 
thus received little attention for nearly two decades. 
However, in the late 1960s and early 1970s several indirect studies 
produced evidence that insulin has its primary action at the cell 
surface. Crofford (1968) demonstrated that the biological effect of 
insulin on isolated fat cells could be rapidly reversed with anti-
insulin serum, suggesting insulin interaction with the cell surface. 
Another investigation showed the lack of insulin response following 
trypsin treatment of isolated fat cells. Trypsin digestion was car-
ried out without loss of cellular integrity, without altering the 
glucose transport system itself and, without impairing cellular re-
sponse to other hormones (Fain & Loken, 1969; Kana, 1969 a, b). The 
evidence from these studies suggested that trypsin destroyed a pro -
tein membrane component necessary for insulin action. 
A further indirect approach was provided by Cuatrecasas (1969). He 
reported that insulin coupled to insoluble agarose (Sepharose) par-
ticles Was biologically active. Because of the relatively large size 
of these hormone-agarose complexes, it was concluded , that the hor-
mone could not enter the cell and, therefore, the metabolic effects 
were a result of hormone-complex interaction with the cell membrane. 
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Although at the time these studies were considered to be definitive 
proof of hormone interaction with the cell membrane, it was later 
discovered that the hormone could be released from the complex du-
ring incubation; the interpretation placed upon these results was 
therefore, in doubt (Butcher et aL, 1973; Davidson et aL, 1973; 
Katzen & Vlahakes, 1973). 
The most conclusive evidence for insulin-membrane interactions was 
provided by electron microscopic studies using a ferritin-insulin 
conjugate (Jarrett et aL, 1974). In these experiments it was obser-
ved that the conjugate bound specifically and irregularly to only 
one side of the fat cell membrane. 
Visualisation of the insulin-ferritin conjugate bound to the mem-
brane provided qualitative proof of insulin interaction with a mem-
brane IIreceptor.1I However, a necessary step in characterising any 
receptor is a study of the binding kinetics of the ligand to the 
receptor. Such studies provide not only qualitative data, but the 
potent dimension of quantitative information is added. Manifestly, 
such knowledge greatly enhances understanding of the dynamic process 
of function. 
In the early 1970s the introduction of a biologically active mono-
iodo-insulin, which is radiolabelled on the A14 tyrosine residue and 
has high affinity binding to liver membranes, led to explosive deve-
lopment in direct insulin binding studies (Freychet et aL, 1971). 
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1.2 METHODOLOGY 
The basic methodology employed for binding studies entails incuba-
ting 125I_Iabelled hormone with the receptor preparation and then se-
paration of receptor bound hormone from the medium containing free 
hormone, either by centrifugation or filtration. 
1.2.1 u5I-Insulin 
Ideally, the iodinated hOrmone should retain the binding character-
istics and the biological activity of the native hormone. Freychet 
et al. (1971) used the mi ld lactoperoxidase method to produce mono-
iodoinsulin. A further refinement of this 125I-insulin was the sepa-
ration of insulin labelled on tyrosine in position A14 from the A19 
substituent (Gliemann et aI., 1979). The 125I_(TYR_A14) insulin was 
shown to have the same biological potency and affinity for the re-
ceptor as native insulin. 125I_(TYR_A19) insulin, by contrast, was 
only half as potent, because the tyrOSine in position A19 is believ-
ed to be in the binding region of the hormone (Pullen et al., 1976). 
Most insulin binding studies since 1980 have used the 125 I_(TYR_A14) 
insulin, which can be separated by ion exchange chromatography. 
1.2.2 Receptor Preparations 
The tissue preparations which have been used in binding studies in-
clude intact cells, particulate fractions of cells and "solubilised" 
cell membranes. There are both advantages and disadvantages to be 
considered when using such preparations. 
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1.2.2.1 Intact Cells 
Isolated intact cell preparations from a variety of different tis-
sues have been used in hormone-receptor studies (Table 1). The iso-
lated cells used in these studies have been obtained from the clas-
sical insulin target tissue such as liver, fat and muscle and, from 
more accessible tissue which is not considered a major target for 
insulin. Non-target tissues such as monocytes, erythroctyes and cul-
tured lymphocytes possess insulin receptors similar to those found 
on the target tissues (Archer et al., 1973a,b; Gambhir et al., 1978; 
Gavin et al., 1973). These metabolically active isolated intact 
cells can be used to correlate hormone binding and biological acti-
vity, although hormone degradation may be higher. The use of enzymes 
such as collagenase, trypsin and hyaluronidase to isolate fat cells 
introduces a variable which can influence the receptor number and 
affinity and hence requires rigid control. Normal circulating lym-
phocytes do not have insulin receptors, however, in vitro transfor-
mation of these cells with mitogens induces large numbers of insulin 
receptors (Krug et al., 1972). These cells become transformed and 
can be maintained in culture indefinitely. Cells in culture can be 
readily isolated for biochemical investigations(Taylor et al., 1982). 
1.2.2.2 Particulate Cell Fractions 
Hormone-receptor interactions have been studied on particulate cell 
fractions from a number of different tissues and have varied from 
crude homogenates to purified plasma membranes (Table 1). These frac-
tions are useful for biological studies and are stable on storage. 
However, it is important to assess plasma membrane yield and pos-
sible contamination with other organelles (Kahn, 1976). 
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Table 1. Isolated Cells for Insulin Receptor Studies 
TISSUE METHOD OF ISOLATION REFERENCE 
Adipocytes Enzymatic Digestion Freychet et aL., 1971 
Cuatrecasas, 1971 
Li ver Enzymatic Digestion Kahn et aL., 1974 
Cultured Cuatrecasas, 1971 
Mechanical Disruption Olefsky et aL., 1974 
Fibroblasts Cultured Gavin et aL., 1972 
Chondrocytes Enzymatic Digestion Hi ntz et aL., 1972 
Muscle Mechanical Disruption Freychet & Forgue, 1972 
Placenta Mechanical Disruption Clark et aL, 1978 
Lymphocytes 
cultured Cultured Gavin et ilL, 1973 
peripheral Isopycnic Centrifugation Archer et aL., 1973 
thymic Mechanical Disruption Goldfine et aL, 1972 
Monocytes Isopycnic Centrifugation Bar et aL, 1976 
Erythrocytes Isopycnic Centrifugation Gambhir et aL, 1978 
Endothelial 
cells Cu I ture Jialal et aL, 1984 
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1.2.2.3 Solubilised Cell Fractions 
Solubilised receptors have been prepared from particulate fractions 
for hormone-receptor studies. There are several criteria used to 
determine whether a receptor is solubilised. These are: failure to 
sediment during ultracentrifugation at 100 OOOg, passage through 
suitably-sized millipore filters or retardation during gel filtra-
tion (Kahn, 1976). Neutral detergents such as Triton X~100 have been 
useful for solubilising receptors (Cuatrecasas,1972). Solubilised 
receptors have been used in structural studies and in characterising 
the chemical composition of the receptor. However, the disruption of 
the membrane phospholipids may result in decreased affinity of the 
receptors for insulin and the number of receptors recovered will 
obviously be affected. A further problem is that the labelled hor-
mone may associate with micelles of the detergent and form a complex 
which on gel filtration, may be mistaken for the hormone-receptor 
complex (Giorgio et aI., 1974). 
1.3 BINDING CHARACTERISTICS OF INSULIN RECEPl'OR$ 
In section 1.2.2.1 it was mentioned that insulin receptors have been 
found in various preparations from nine different tissues. However, 
not all these tissues are responsive to insulin and although insulin 
binds to the receptor, there is no biological effect. Despite the 
lack of metabolic effects in some of these tissues, several binding 
characteristics are common to all cells. These include specificity, 
kinetics of binding, temperature dependency and the effect of pH and 
specific ions. 
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1 .3. 1 Spec if i city 
It is generally accepted that the word "receptor" refers to a mole-
cule or molecular complex which is capable of specifically recogni-
sing a particular ligand, and interacting with it in such a way that 
a biological response is effected. 
An important property of the i nsu 1 in receptor is its ab iii ty to re-
cognise and interact with a single hormone, insulin. In some cases, 
various insulin analogues and peptides with insulin-like activity 
will bind to the receptor, but their affinity for the receptor is 
directly proportional to the biological effect they exert. For in-
stance porcine, bovine and human insulin have the greatest affinity 
for receptors on liver membranes and cause maximal glucose oxidation 
in fat cells. Proinsulin and desoctapeptidehave a lower affinity 
for liver membrane receptors and a proportionally lower effect on 
glucose oxidation in fat cells (Freychet et al., 1971). 
1.3.2 Insulin-like Growth Factors (IGFs) 
A more complicated relationship exists between insulin and the insu-
lin-like growth factors (IGFs). Olez et al. (1972) described a serum 
protein which lacked insulin immunoreactivity, but had weak insulin-
"like effects on glucose utilisation and lipid metabolism, and was 
more potent than insulin in stimulating cell growth. This protein 
was called "non-suppressible insulin-like activity" (NSILA). It was 
later demonstrated that NSILA bound to the insulin receptor with a 
low affinity and its metabolic effects were mediated via the insulin 
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receptor. Likewise, insulin bound to the NSILA receptor with low af-
finity and the growth effects of insulin were mediated through this 
receptor (Megyesi et al., 1974). The NSILA serum protein was identi -
fied by Rinderknecht & Humbel (1978a) as two distinct proteins which 
were called the insulin-like growth factors I and II (IGF-I and 
I GF - II) . 
The structures of IGF-I and IGF-II have been elucidated (Rinder-
knecht & Humbel 1978a,b). They are homologous and are structurally 
similar to insulin (Fig. 1.1). An interesting distinction between 
the IGFs and insulin is the retention of the connecting-peptide 
(C-peptide) by the former, whereas this structural peptide is remo-
ved in the conversion of proinsulin to insulin. As a result, insulin 
consists of two polypeptides linked by disulphide bonds, while the 
IGFs are single chains (Froesch ~t aZ., 1985). 
It has also been established that two subtypes of receptors for IGF 
exist. The type I receptor has a similar structure to the insulin 
receptor but, has a greater affinity for IGF-I than IGF-II and a 
weaker affinity for insulin. The type II receptor has a different 
structure from the other two receptors and it does not bind insulin. 
Both IGF-I and IGF-II, however, bind with low affinity to the insu-
lin receptor (Rechler & Nissley, 1985). 
Recent studies have shown that the type 1-IGF receptors and insulin 
receptors are homologous structures (Massague & Czech, 1982). In ad-





SOhematic representation of the three-dimensional 
structure of insulin based on the x-ray analysis of 
Rhombohedral Porcine 2-Zn insulin crystals and 
proposed conformations based on model building for 
proinsulin and IGF-I showing the close structural 
homology. C, C-Domain; D, D-Domain. (Reproduced from 
ZAPF et aZ , 1981). 
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and both receptors are downregulated by IGFs and insulin (Rosenfeld 
et aI., 1982). 
InitialLy it was proposed that growth factor receptors mediated cell 
proliferation and insulin receptors mediated acute metabolic effects. 
However, there is an increasing number of important exceptions to 
this simple rule (Czech, 1982). For example, in the rat hepatoma H35 
cell line insulin stimulates cell growth via the insulin receptor, 
whereas both classes of peptides stimulate glucose transport and me-
tabolism via IGF receptors in human skin fibroblasts (Knight et al., 
1981; Koontz & Iwahash i, 1981). 
It should be mentioned that although insulin-like growth factors are 
present in serum in great excess (1 ~g/mi), they are bourid to speci-
fic carrier proteins. In this form they do not appear to bind readi-
ly to the insul in or IGF receptor (Zapf, 1979). 
1.4 KINETICS OF BINDING 
The purpose 6f kinetic analysis is to obtain quantitative data on 
the nature of insulin binding to the receptor at cellular and mole-
cular levels. These data are useful in describing receptor-binding 
models. Such studies are generally carried out under steady state 
conditions in which the law .of mass action applies. However, before 
steady state binding experiments can be undertaken, it is important 
to establish the optimal conditions for insulin binding to the 
receptor. 
12 
1.4.1 Receptor Binding Assay 
In section 1.2 the basic requirements for the insulin binding assay 
have been detailed. Given these requirements, the principle of a com-
petitive binding assay is to incubate an insulin preparation with phy-
siological concentrations of labelled insulin in the presence of 
increasing concentrations of unlabelled insulin, ynder equilibrium 
conditions. This is followed by measuring the decrease in bound label-
led insulin (Fig. 1.2). The concentrations of unlabelled insulin em-
ployed range from "tracer" levels (0,2 ng/m2) at which only a small 
number (1%) of receptors are occupied, to very high levels (105 ng/m.Q). 
The percentage of bound 125I-insulin decreases as the total insulin 
concentration increases and all data are corrected for non-specifi~ or 
nonsaturable binding (Cuatrecasas, 1971). 
In all systems, hormone binding consists of at least two prOcesses, 
one of which is saturable or t'specific" and the other of which is non-
saturable or "non-specific." In the physiological range, most binding 
occurs to the specific binding sites which, by definition, are finite 
in number. The non-specific binding is generally defined as the amount 
of insulin bound in the presence of 103 - 1~ ng/m2 unlabelled insulin , 
(Kahn, 1975). 
1.4.1.1 pH and Specific Ions 
Insulin binding studies should be carried out under physiological con-
ditions, because extremes of pH, temperature and ionic composition in 






.01 . 1 1 10 100 
Peptide concentration (n molll) 
Displacement or competition curves for homolologous 
(A-A) (chemically identical) and heterologous (e-e) 
(Chemically different) competitors. ID50's are 
indicated with the vertical dashed lines. The 
important characteristics of the curve include upper 
and lower plateau levels, ID50 location and slope 
factor (reproduced from Munson and Rodbard, 1983). 
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For instance, it is now well established that most tissues have a dis-
tinct pH optimum, between pH 7,6 and 8,0, at which insulin binds to 
its receptor (Gavin et aI., 1973). 
The influence of specific ions such as Ca++ and Mg++ is not as consis-
tent. For example, in cultured human lymphocytes increasing concentra-
tions of Ca++ have no effect on binding (Gavin et aI., 1973), whereas 
in isolated fat cells increased binding has been reported in the pre-
sence of high Ca++ concentrations (Desai et aI., 1978). 
However, increased binding on fat cell plasma membranes was observed 
at high ionic strength (Cuatrecasas, 1971). This could account for the 
high binding reported in the presence of increased Ca++ concentrations 
for fat cell binding studies. 
From these data it appears that insulin binding is not dependent on 
Ca++ and Mg++ as specific co-factors, although a high ionic strength 
does marginally increase binding. 
1.4.1.2 Temperature Dependency 
Both the rate and steady state level of insulin binding are dependent 
on temperature. However, the amount of insulin bound at higher tempe-
ratures is consistently lower, because the rate of dissociation of 
insulin bound to receptor is accelerated to a greater extent than the 
association rate under these conditions, this leads to an apparent 
overall decrease in the affinity (Ginsberg, 1977). 
Higher temperatures also lead to an increase in the internalisation 
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and degradation of insulin and the receptor, which results in an appa-
rent decrease in insulin binding to the receptor. 
1.4.2 Kinetic Analysis 
Binding of radiolabelled insulin to insulin receptors can be described 
by the law of mass action. According to the law of mass action the 
hormone-receptor interaction can be expressed by the equation 
k1 
[R] + [H] ~ [RH] 
k2 
where R is receptor, H is hormone and RH is the hormone-receptor com-
plex, k1 is the tate constant of association and k2 is the rate con-
stant of dissociation. 
Once optimal steady state binding conditions have been established and 
the insulin binding assay has been carried out, the data can be analy-
sed by plotting the ratio of bound and free hormone (B/F) versus bound 
(B) (Scatchard, 1949). This graphical representation of insulin bind-
ing enables the calculation of the equilibrium constant (K) and the 
number of receptors (R) present in the preparation. The mathematical 
formulation of the Scatchard plot will be described in Chapter 3. 
Scatchard plots of insulin binding in adipocytes, liver membranes and 
human lymphocytes are all typically curvilinear with upward concavity 
(Gamme Itoft, 1984). In it i ally th i s was interpreted as i nd ieat i ng two 
types of binding sites: a high affinity, low capacity site and a low 
affinity, high capacity site. Later, De Meyts et al. (1973) provided 
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direct evidence for site-site interactions between insulin receptors 
and suggested a model for negative co-operativity. Based on their data 
the model proposes that insulin binding sites are homogeneou~ but the 
binding affinity decreases with increasing occupation of the sites by 
insulin. The affinity of the sites is thus not represented by a fixed 
binding constant: the model predicts that it varies as a function of 
receptor occupancy (De Meyts & Roth, 1975). 
A graphical representation of negative co-operativity called the ave-
rage affinity profile, was described. The mathematical derivation of 
this plot will be discussed in more detail in Chapter 3. 
Although the model for negatively co-operative site-site interactions 
does explain the curvilinear Scatchard plot, some workers disagree 
with the experimental evidence and have shown that the dissociation 
rate is independent of receptor occupancy (Pollet et al., 1977). More 
recent evidence using a double probe labelling (DPL) technique, has 
shown that each insulin receptor binds two insulin molecules. The 
-u 
first molecule is bound with a high affinity (K d - 6 x 10 mol/I) and 
the second molecule of insulin is bound With a much lower affinity 
_8 
(K 4 - 8 x 10 mol/l). The presence of two distinct binding sites with 
different affinities on a single receptor unit is consistent with the 
model for heterogenous binding sites. However, the presence of site-
site interactions cannot be excluded and it has been suggested that 
insulin binding ~ to the receptor is a combination of both heterogeneous 
binding sites and negative co-operativity (Pang & Schafer, 1984). 
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Recent evidence that most cell types possess both insulin receptors, 
which bind insulin with a high affinity, and type I IGF receptors , 
which bind insulin with a lower affinity favours the model for hetero-
geneous binding sites (Rechler & Nissley, 1985). 
On the other hand, studies using a variety of monoclonal antibodies 
have shown that the insulin receptor can exist in different conforma-
tional states which are stabilised by ligand induced site-site inter-
actions (Gu et al., 1988). These data support the negative co-operati-
vity model. 
1.5 INSULIN RECEPl'OR STRUCTURE 
1.5.1 PhYSicochemical Properties 
Early indirect experiments suggested that the insulin receptor is pro-
tein in nature. Trypsin treatment decreased the receptor numbers in 
plasma membranes and in solubilised preparations of receptor obtained 
from human placentae, adipocytes, and human lymphocytes (Clark et al., 
1978; Kana & Barham, 1971; Gavin et al ., 1973). Treatment of cells 
with neuraminidase and plant lectins indicated that specific carbohy-
drate moeities are components of the receptor (Cuatrecasas & lIliana, 
1971 ) . 
Solubilised receptors have been characterised as asymmetric proteins 
o 
with a Stokes radius of 70-72 A (Cuatrecasas, 1972; Gavin et al., 
1972). The insulin receptor complex has a sedimentation coeffiCient of 
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11S, suggesting an indicated molecular weight of about 300 kD (Pollet 
et a L ., 1981). 
1.5.2 Subunit Structure of the Insulin Receptor 
A variety of techniques has been used to establish the subunit struc-
ture of the insulin receptor. It is now well established that the re-
ceptor cons i sts of two subun i ts denoted CI. and B . 
Using affinity chromatography the CI. subunit was isolated and identi-
fied by sodium dodecyl sulphate (SDS)-gel electrophoresis of solubi-
I i sed receptor (Jacobs et aL., 1980) . It has an apparent molecular 
weight of 125-135 kD. These results have been confirmed using affinity 
labelling, photo-affinity labelling and immunoprecipitation of the re-
ceptorwith anti-receptor antibodies (Yip et aL., 1978; Pilch & Czech, 
1979; Kasuga et aI., 1981b). 
This subunit is the dominant labelled species observed when the recep-
tor is affinity labelled by12I-insulin using the bifunctional chemical 
cross linker disuccinimidyl suberate (DSS), a finding which suggests 
that it probably contains the insulin binding site. Furthermore, com-
petitive inhibition with unlabelled insulin decreases the amount of 
125 I ' I -lnsu in crosslinked to the CI. subunit which shows that affinity la-
belling of this subunit is specific for insulin (Pilch & Czech, 1980). 
The CI. subunit has been identified in receptors prepared from cultured 
human lymphocytes, monocytes, muscle, rat liver membranes, adipocytes 
and endothelial cells (Czech, 1985). 
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The B subunit is also a glycoprotein and has an indicated molecular 
weight of 95 kD. It has been isolated by affinity chromatography 
(Jacobs et al., 1980) and is the lesser species observed in SDS gels 
after crosslinking the insulin-receptor complex with DSS. This finding 
suggests that the B subunit is not normally active in binding insulin 
(Czech et aL, 1981). 
The Q and B-subunits have been shown to be present in equal quanti-
ties within the receptor complex (Fujita-Yamaguchi, 1984). In fact, 
there is increasing evidence that the Q and B-subunits are synthesised 
in the cell from a single polypeptide precursor which is first glyco-
sylated and, thereafter, undergoes proteolytic cleavage before inser-
tion into the cell membrane (Hedo & Gorden, 1985}. The mature membrane 
receptor is a heterotetrameric disulphide-linked complex consisting of 
two Q and B-subunits, with an apparent molecular weight of 300-350 kD 
(Fig. 1.3) (Czech et al., 1981; Jacobs & Cuatrecasas, 1981). From the 
I 
proposed receptor model it appears that each Q-subunit has the ability 
to bind a single hormone molecule which suggests that the receptor is 
bivalent. 
1.6 RECEPTOR FUNCTIONS 
Understanding of the protein chemistry of the insulin receptor is ba-
sed on an assumption that insulin receptor functions are directly re-
lated to the insulin receptor structure. For instance, specific struc-
tures within the receptor complex must partiCipate in such processes 
as biological signal transduction~ ligand-induced receptor internali-
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A schematic model of the insulin receptor structure. 
The receptor unit is composed of two ~ subunits and 
two S' subuni.ts which are linked by disulphide bonds. 
Thea subunit is found on the cell surface, whereas 
the 8 subunit forms part of the inner membrane. 
Insulin binds to receptor sites on the a subunit 
which induces auto phosphorylation of the 8 subunit. 
Protein kinase activity is associated with the 8 
subunit. (Adapted from Czech, 1985). · 
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1.6.1 Tyrosine Kinase Activity 
An important breakthrough in the elucidation of insulin receptor func-
tion was the finding that, in the presence of ATP, insulin induces 
tyrosine phosphorylation of the receptor ' s B subunit. Once phosphory-
lated, the B subunit will, in turn, phosphorylate tyrosine moeities on 
intracellular proteins. However, at present no physiologically rele-
vant endogenous substrate has been identified (Stadtmauer & Rosen, 
1983) . 
There is some doubt as to whether these phosphoryl at ions playa role 
in mediating the metabolic actions of insulin. The reason for this 
controversy is that the anti receptor antibodies, which mimic insulin 
action, vary with respect to their ability to stimulate the receptor-
associated protein kinase activity (Taylor, 1985). 
1.6.2 Intracellular Processing of Insulin 
Considerable evidence now indicates that after insulin has bound to 
the receptor on the plasma membrane, the insulin-receptor complex is 
internalised by the process of endocytosis. This process is ligand-
induced and the main functional consequences appear to be removal of 
the hormone from the external environment with subsequent hormone de-
gradation and receptor regulation. 
1.6.2.1 Internalisation of Insulin 
Based on electron microscopy studies, the sequence of binding and 
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Schematic drawing of receptor mediated endocytosis. 
The pathway includes steps (1) the microvilli, (2) 
coated pits, (3) fusion of the coated pit, (4) coated 
vesicle, (5) non-coated vesicle .or endosome, (6) 
multivesicular body, (7) lysosome. The solid arrows in 
steps 4-6 represent points at which membrane 
receptors can recycle back to the plasma membrane. 
The dashed arrow indicates that recycling could also 
occur by way of de novo (receptor synthesis. The 
reservoir indicates the possibility of a pre-formed 
pool of intracellular receptors. (Reproduced from 
Carpentier et aL , 1986). 
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either bind initially to receptors on the microvilli and then move 
into the coated pits by lateral mobility (Schlessinger et al., 1980) 
or the ligand binds directly to receptors in the coated pits (Fan 
et al., 1982) (Fig; 1.4). The neck of the coated pit then fuses and a 
coated vesicle is formed which has a short half-life (Carpentier 
et aI., 1986). By some unknown mechan i sm the coat is shed, and the 1 a-
belled ligand is next associated with a larger clear vesicle called an 
endosome (Fan et al., 1983). The presence of a proton pump in its mem-
brane allows the acidification of the vesicle's internal milieu (Tycko 
& Maxfield, 1982). This acidification step is regarded as important in 
the processing of the insulin-receptor complex because decreased pH 
promotes dissociation of the ligand from the receptor. Further pro-
ceSSing of insulin was visualised in a multivesicular body composed of 
small vesicles thought to be the result of endosomal fusion (Carpen-
tier et al., 1986) The final processing Of ligand seems to take place 
in the lysosomes (Fan et aI., 1983). 
A number of polypeptide hormones including insulin, epidermal growth 
factor and growth hormone are degraded primarily in the lysosome by 
acidic proteases (Carpentier et aI., 1986). 
Biochemical studies using a mild acid treatment to remove membrane 
bound labelled ligand with subsequent measurement of intracellular 
label, have confirmed the morphological demonstration of ligand inter-
nalisation (Haigler et aI., 1980). These studies have demonstrated 
ligand internalisation in adipocytes (Kahn & Baird, 1978), endothelial 
cells (Jialal et aI., 1984) and mouse melanoma cells (Shimizu et aI., 
1981 ) . 
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The fate of the insulin receptor following internalisation is not as 
straightforward as insulin. The receptor may be degraded, recycled or 
both s i tuat ions may app ly (Carpent i er ~t aZ ., 1986). 
1.6.2.2 Insulin Degradation 
As mentioned in section 1.6.2.1, insulin is internalised and degraded 
in the lysosomes by acidic proteases. The degradation products rapidly 
leave the cell, so at any given time only a fraction of cell-associa-
ted insulin is in this compartment. 
Biochemical studies have clearly demonstrated the role of the lysosome 
in the degradation of internalised insulin. For example, chloroquine, 
a lysosomotropic agent, inactivates the intralysosomal acidic protea-
ses by increasing lysosomal pH (Marshall & 01efsky, 1979). Treatment 
of cells with chloroquine before carrying out binding studies depres~ 
ses insulin degradation resulting in an increase of cell-associated 
intact r~I-insulin. 
Two specific enzymes with the ability to degrade insulin have been 
isolated from target tissues for insulin action and have been hypothe-
sised to function in insulin degradation in vivo (Duckworth & Kitabchi 
1981). Insulin degrading enzyme (IDE) which is found mainly in the cy-
tosol fraction has also been isolated from media pre-incubated with 
IM-9 cultured lymphocytes (Roth et aZ., 1985) and has been demonstra-
ted on the cell surface of IM~9 lymphocytes, rat hepatoma cells and 
primary cultures of rat hepatocytes (Yokono et aZ., 1982). The second 
enzyme, glutathione-insulin transhydrogenase (GIT) is located prima-
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rily in the microsomal fraction of the cell (Varandani, 1978) and was 
not detected on the plasma membrane of the IM-9 lymphocytes (Yokono 
et aI., 1982). 
Receptor-mediated lysosomal degradation of insulin has been demonstra-
ted in rat fat cells, human monocytes, human adipocytes and human H4 
hepatoma cells (Gliemann & Sonne, 1978; Beck-Nielsen & Pedersen, 1979; 
Pederson et aI., 1981; Hofmann et aI., 1980). However, this degrada-
tive pathway for insulin was absent in both human IM-9 lymphocytes 
(Sonne & Gliemann, 1980) and human cultured lymphocytes RPMI-1788 cell 
125 
line (Maegawa et aI., 1983). In cultured endothelial cells I-insulin 
is rapidly internalised with minimal degradation and it has been sug-
gested that this process serves to transport insulin from the intra-
vascular space to the sub-endothelial tissues (Jialal etaI., 1984). 
The function of this receptor-mediated degradation has been viewed in 
several ways. Firstly, the receptor binding and subsequent internali-
sation of insulin is an efficient mechanism for removing insulin from 
the circulation. Secondly, the removal of insulin from the cell sur-
face and its subsequent degradation could terminate insulin action 
(Gliemann et aI., 1975). Thirdly, it has been suggested that the de-
gradation fragments may be involved in the biological action of insu-
lin ie. a second messenger system (Kikuchi et al., 1980). Fourthly, 
the internalisation of the insulin receptor complex and subsequent de-
gradation of insulin may play an important role in the ligand-induced 
downregulation of receptors and cellular desensitisation to insulin 
(Kosmakos & Roth, 1980; Krupp & Lane, 1981). 
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1.6.3 Downregulation 
An important consequence of insulin-receptor endocytosis is ligand 
induced loss of membrane receptors, commonly known as IIdownregulation ll 
( Ga v i n et a I ., 1974). 
Clearly, this phenomenon plays an important role in modulating cell 
surface receptor numbers. It has been suggested that insulin induces 
downregulation by increasing receptor degradation rather than inhibi-
t ing receptor b iosynthes is (Kosmakos & Roth, 1980; Kasuga et aI., 
1981a). At present, no linear relationship between downregulation and 
degradation of the receptor has been established, probably because of 
the added complication of measuring receptor recycling. For instance, 
Carpentier at al. (1984) have demonstrated that individual cell lines 
have different rates of insulin receptor internalisation which, in 
turn, determine the rate of receptor recycling. 
Thus the regulation of cell surface receptors is not only determined 
by the hormone-induced receptor degradation, but is also a function of 
the cellular rate of internalisation and receptor recycling. 
Downregulation of the insulin receptor is associated with a number of 
disease states in man in which chronic hyperinsulinaemia and insulin 
resistance are present. 
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1.? INSULIN RECEPI'ORS ON NON-TARGET CELLS IN DISEASE STATES 
One of the major problems involved in studies of insulin binding and 
insulin action is that target tissues are not usually available for 
routine clinical investigations. However, as mentioned in section 
1.2.2.1, non-target tissues such as monocytes, erythrocytes and 
transformed lymphocytes have insulin receptors which are similar to 
those found on target cells. These findings have led to a great deal 
of research on insulin receptor binding to non-target cells in normal 
and disease states. There are advantages and disadvantages associated 
with the different cell types. 
1 • 7. 1 Monocytes 
Circulating monocytes isolated from peripheral blood have been used to 
study insulin binding and insulin receptor functions in patients with 
insulin resistance (Bar et aL., 1976; Grunberger et aI., 1983). 
Although these cells are relatively simple to isolate, large volumes 
of blood must be drawn to obtain enought cells for binding studies. 
1.7.2 Erythrocytes 
Erythrocytes have been used for receptor binding studies in normal and 
disease states (Dons et al., 1981 a) . 
The major advantage of these cells is the small quantity of blood 
required for binding studies. 
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However, circulating erythrocytes do not have nuclei and they lack the 
enzymes necessary for de novo protein synthesis. As a result the 
number of insulin receptors on the cell surface decreases with eryth-
rocyte age (Dons et aZ., 1981b). Therefore, when interpreting insulin 
binding data on erythrocytes the mean age of circulating erythrocytes 
should be taken into account. 
A further disadvantage of this cell type is the presence of type I IGF 
receptors (Polychronakos et aZ., 1983). If the number of high affinity 
insulin binding sites is decreased, insulin pinding would reflect bin-
ding to the type I IGF receptor which has a lower affinity for insulin. 
Kinetic analysis of decreased insulin binding, in cell types which 
possess type I IGF receptors, should include competitive binding stu-
i25 dies between I-insulin and unlabelled IGF-I to determine the degree 
of cross-reaction. 
1.7.3 Cultured Fibroblasts 
It is relatively simple to establish human skin fibroblasts in culture. 
These cell lines are grown under standard conditions and any changes 
in insulin binding or insulin action would reflect defects which are 
intrinsic to the cell line. There are two major disadvantages in using 
fibroblasts for receptor studies. Firstly, biochemicat studies gene-
rally require large numbers of cells. As human fibroblasts have a 
finite lifetime in culture it is difficult to grow sufficient quanti-
ties of cells for these studies. Secondly, cultured skin fibroblasts 
have large numbers of type I IGF receptors (Rechler & Podskalny, 1976). 
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In section 1.3.2, it was mentioned that both insulin and IGF-I stimu-
late glucose transport via the type I IGF receptors in human skin 
fibroblasts. These observations further complicate the interpretation 
of insulin binding and insulin action on this cell type. 
1.7.4 Epstein-Barr Virus Transformed B-Lymphocytes 
As previously mentioned in section 1.2.2.1, normal circulating lympho-
cytes do not possess cell surface insulin receptors~ Transformation of 
B-Iymphocytes in vitro with Epstein-Barr virus (EBV) induces signi-
ficant numbers of insulin receptors. These cells can then be grown in 
culture in large quantities which enables detailed biochemical studies. 
In addition, EBV transformed lymphocytes do not have detectable num-
bers of type I IGF receptors (Taylor ~~ al., 1982). 
Although there is a good correlation between genetic defects observed 
in EBV lymphocytes and peripheral monocytes (Taylor et al., 1981), 
there is a possibility that incorporation of the EBV genome into the 
lymphocytic DNA could affect gene expression. Recent studies using 
insul in receptor complementary DNA suggest that expression of the 
insulin receptor gene occurs normally in EBV transformed lymphocytes 
in normal and insulin-resistant patients (Yoshimasa et al.~ 1988; Kado-
wak i et al. ~ 1988). 
A number of receptor functions including downregulation and phosphory-
lation have been demonstrated in these cell lines (Wagman et aI., 1983; 
Whittaker et aI., 1985). However, intracellular processing of insulin 
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and the biological effects of insulin on these cell lines have not 
been reported. 
1.8 INSULIN RECEPTORS ON LYMPHOCYTES 
1.8.1 The Role of Insulin Receptors During Normal Lymphocyte 
Activation 
Both B-lymphocytes (bone marrow derived) and T-Iymphocytes (thymus de-
rived) perform an essential role in the immune response. The lympho-
cyte response to antigen stimulation is an ordered sequence of events. 
After interaction with the antigen, metabolic activation occurs, then 
cell proliferation and finally cell differentiation (Fig. 1.5). There 
is a significant increase in the number of cell surface insulin recep-
tors during the second stage of this response. It has recently been 
suggested that these receptors playa 'Isupportive ll role by influencing 
cell metabolism (Marchalonis & Galbraith, 1987). The third stage of B-
lymphocyte activation is triggered by a B-cell growth factor (BCGF) of 
T-cell origin. In order to stimulate cell proliferation this hormone-
like lympho~yte-active peptide must bind to a BCGF receptor on the B-
lymphocyte. Although recent studi~s support the conceptual identifica-
tion of BCGF, the molecular identity of this factor and its receptor 
have not been established (lola, 1985). 
An interesting finding is that normal B-Iymphocytes transformed by 
















conceptual model of normal B cell response. After 
interactions with antigen, B cells proceed under 
optimal conditions through an orderly sequence of 
metabolic activation, proliferation (clonal 
expansion), and differentiation (acquisition of 
effector function). The progress of B cells to 
proliferation depends on the expression of both B 
cell growth factor (BCGF) and B cell differentiation 
factor (BCDF) receptors. Interaction of BCGF with its 
receptor "triggers" the proliferative phase. The 
insulin receptor seems to facilitate proliferation 
and is therefore a "supportive" receptor (reproduced 
from Marchalonis and Galbraith, 1987). 
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Lymphoma produce an autostimulatory factor which is similar to BCGF 
(Gordon et aI., 1985). 
1.8.2 The Raji Cell Line 
The IlRaji ll cell line was first established in culture by Pulvertaft 
(1964) from tissue which was taken from a Nigerian patient with Bur-
kitt's Lymphoma (BL). It is now well established that most BL cell 
lines, including the Rajis, harbour several copies of the EBV genome 
(Klein & Klein, 1985). In addition, the Rajis produce an autostimula-
tory factor resulting in an autocrine loop (Gordon et al., 1985). 
If the Raji cells display insulin receptors which are similar to those 
on target cells, then the former cell line could be used as a model 
for studying the kinetics, structure and function of insulin receptors 
induced by EB virus. 
The aim of this thesis is to show that Raji cells express a true 
insulin receptor which is not an artifact of viral transformation. The 
characteristics of the insulin receptor will be analysed as follows: 
Firstly, it will be established that Raji cells have a specific insu-
lin receptor which binds insulin with a high affinity and has similar 
binding characteristics to receptors on target cells. In order to de-
termine the most accurate receptor model for insulin-receptor inter-
action, the kinetics of insulin binding are studied in detail. 
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Secondly, to show that the insulin receptor on Raji cells is func-
tional, endocytosis of the insulin-receptor complex and subsequent 
processing of insulin are investigated. 
Thirdly, the molecular structure of the high affinity insulin binding 
site is elucidated. 
Finally, cross-reaction between insulin and IGF-I is studie.d to deter-
mine whether Raji cells display type I IGF receptors. In addition, the 
biological response of Raji cells to both peptides is correlated with 
binding studies to determine which receptor is mediating a particular 
response. 
CHAPTER 2 
BINDING CHARACTERISTICS OF INSULIN RECEPTORS 
IN RAJI CELLS 
OptinnI conditions are assu17¥3d to be definabIe 




As mentioned in section 1.8, the Raji cells provide a useful model 
system for studying insulin ~inding to human lymphocytes which have 
been transformed by the Epstein-Barr virus (EBV). If these studies 
are to be extended to disease states, it is important to establish 
whether this virally induced insulin receptor exhibits the same bin-
ding characteristics as the receptor on classical target cells. 
The principle of the insulin binding assay was previously discussed 
in section 1.4. In this chapter 125 I-insulin has been used to direct-
ly study insulin binding to the membrane receptor on Raji cells. 
Other important considerations in characterising insulin binding to 
the receptor include the specificity of binding, steady state bind-
ing, temperature dependency, and the effect of reaction conditions 
such as pH, buffers and specific ions. 
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2.2 MEASUREMENT OF 125I-INSULIN BINDING TO RAJI CELLS 
2.2.1 Reagents 
Reagents used in these studies were commercially available grades of 
the highest purity from various manufacturers: labelled insulin was 
human A14 - 125I_monoiodo insulin (specific activity 200-300 UCi!llg) 
supplied by Amersham (UK); unlabelled insulin was human monocompo-
nent insulin supplied by Novo Industries (Denmark). HEPES (N-2-Hy-
droxyethylpiperazine-N'-2-ethanesulphonic acid) was obtained from 
Sigma Chemicals Company (USA). Tris (hydroxymethyl) methylamine was 
supplied by BDH Chemicals Ltd., (England). Manufacturers of specific 
chemicals are listed in the relevant sections. Distilled water 
was used at all times. 
Hi-Radioactivity was counted on a Berthold LB 2100 multi-crystal 
gamma counter. 
2.2.2 Raji Cell Line 
The origin of the Raji cell line was discussed earlier in section 
1.8.2. 
2.2.2.1 Morphology 
Morphologically the cells are slightly different from normal lymph-
cytes. They are larger than small lymphocytes and are markedly gra-
nular (Fig. 2~1). In culture the cells adhere to each other in 
clumps which are readily dispersed with gentle agitation. The cells 




The Raji cells are slighty larger than normal 
lymphocytes. Their cytoplasm is granular and they 
appear to grow in clumps. (Magnification x 800 ) . 
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2.2.2.2 Maintenance of Cells in Culture 
The Raji cells were grown in 80 cm2 flasks (Nunc, Denmark) in RPMI 
1640 medium (Flow Laboratories, UK) containing 10% foetal calf serum 
(Gibco, UK) and supplemented with penicillin (100 U/ml),streptomycin 
(100 ~g/ml) and fungizone (0,25 ~g/ ml) (Gibco, UK). Cultures were 
maintained at 37°C in an atmosphere of 5% CO 2 in air with a relative 
humidity of 85% and fed every 3-4 days; a 1:3 split with medium 
was carried out every 8-10 days. 
2.2.3 Insulin Binding Assay 
2.2.3.1 Composition of the Binding Assay Buffer 
HBB (Hepes binding buffer) pH 8,0 
100 mmol/l HEPES (N-2-Hydroxyethylpipe.razine-N'-2-ethanesulphonic 
acid 
120 mmol/l Sodium chloride (NaCI) 
1,2 mmol/l Magnesium sulphate (MgS04 ) 











Sodium acetate (NaC~ COO. 3H
2
0) 
Bovine serum albumin (BSA). 
2.2.3.2 Procedure 
The Raji cells were grown until stationary growth phase was reached 
6 
(1-2 x 10 cells/ml). Cells were not "fed" for 3-4 days prior to the 
insulin binding assay to prevent possible downregulation of the 
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receptor by insulin in the foetal calf serum (FCS) (Gibco FCS insu-
lin = 8,65 ±1,2~U/m.o. A schematic representation of the procedure 
followed is given in Figure 2.2. Cells were harvested by spinning 
at 200 x g in a bench top centrifuge for 5 min at room temperature; 
the packed cells were then resuspended in HBB and recentrifuged. The 
cells were washed three times in the HBB and resuspended in the same 
buffer at a concentration of 1-2 x 10 7 cells/mf. The incubation mix-
ture for the binding assay consisted of 400 ~f of cells in HBB, 
50 ~ f 125I_insul in (final concentration of about 0,2 ng/ml) and 50 ~ f 
of unlabelled insulin (final concentration of about 10 ng/mf). The 
incubation mixture was maintained at 15°C for a period nf 120 min 
unless otherwise stated. After incubation 200 ~ f portions of suspen-
ded cells were removed and layered onto 200 ~ f of ice cold HBB in 
Beckman microfuge tubes. These were then spun in a Beckman microfuge 
(8740g) at 4°C for 2 min. The supernatant was removed and the cell 
pellet was counted in the Berthold multi-head gamma counter. Total 
counts per minute (cpm) were obtained by pooling the remaining 
100 ~f of the 500 ~f incubation mixture and counting the radioacti-
vity in 200 ~..e portions. The binding studies were carried out accor-
ding to the method of Gavin et al. (1973). 
2.2.4 Data Analysis 
Data were expressed as maximum % specific binding. Non-specific bin-
d ) 125 ing (NSB was defined as the amount of I-insulin bound to the 
cell pellet in the presence of 10 5 ng/mf unlabelled insulin. The NSB 
was subtracted from total binding (B T) to give specific binding 
(Sp. B). 125 I-Insulin specifically bound was then expressed as a 
CELL CONCENTRATION 
1-2x10 6 CELLS/ML 
200 gAT R T 
WASH x3 IN HSS 
200 g AT RT 5 MIN 
RESUSPEND CELLS IN HBS 




(1) 400 ~L CELLS IN HBB 
...... 411--- (2) 50 ~L l25I-INSULIN (0,2 NG/ML) 
.... 
COUNT THE RADIOACTIVITY REMAINING 
IN THE PELLET IN A GM1NA COUNTER 
(3) 50 ~L UNLABELLED INSULIN ( 10 5 NG/Ml) 
INCUBATE AT 15°C fOR 
120 MIN 
REMOVE 200 pL ALIOUOTS AND 
LAYER ONTO 200 pL HBB AT 4·C 
8740 g AT 4·C (BECKMAN MICROfUGE) 
ASPIRATE THE SUPERNATANT 
Fig. 2.2 A schematic outline of the insulin binding assay. 
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function of cell concentration which was usually 10
7 
cells/ml. 
Finally, the data were divided by the total amount of radioactivity 
in 200 ~l portions of incubation mi xture and expressed as percentage 
125I_insulin specifically bound (% Sp.B). Calculation of % Sp.B. per 
10 7 cells/ml is detailed below. 
Calculation 
BT: - NSB = Sp.B ... ~ ....... (1) I 
Sp.B. x 1 x 10
7 cells/ml = 
? cells/mi 
Sp.B. per 10 7 cells/ml ... (2) 
Sp.B. x 100 = % Sp.B. per 10
7 cells/ml 
TOTAL COUNTS. 
2.2.5 Measurement of the Affinity Using ID so 
Although Scatchard plot (equation 7, section 3.2) is the most widely 
used method for measuring the affinity of the insulin receptor, the 
IOsocan be used as a rough index of affinity. The IOso is defined as 
the concentration of unlabelled insulin required for displacement of 
one-half the maximum of 125 I-insulin specifically bound and it is 
calculated from the competition curve (Grunberger et al., 1983). 
This parameter originates from the Michaelis-Menten constant (KM) 
(Lehninger, 1975) . A similar measurement was termed the pAhand was 
used to determine the concentration of drug antagonist which depres-
ses the agonist effect by one-half (Schild, 1957). 
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2.3 DETERMINATION OF OnIMAL CONDITIONS FOR INSULIN BINDING TO 
RAJI CELLS 
Prior to kinetic studies of insulin binding, the optimal reaction 
conditions for insulin-receptor binding were determined. 
2.3.1 Measurement of Cell Growth 
Cells were split (1:10) to give a final cell density of about 2 x 10 
cells/mR. The cell suspension was distributed between three 25 cm 
2 
flasks (Nunc) and incubated under normal conditions as described in 
section 2.2.2.2. Cells were counted at regular 24 hr intervals for 6 
days and a graph of mean cell number versus time (days) was plotted. 
2.3.2 Competitive Binding Assay 
5 
A competitive binding assay was carried out by incubating a fixed 
amount of 125I-insulin ( 0,2 ng/mR) with the receptor preparation 
(Raji cells) in the presence of increasing concentrations of unla-
belled insulin. The concentration of unlabelled insulin in the incu-
. 5 
bation mixture ranged from 0 ng/mR to 10 ng/mR. Incubation was car-
ried out as previously described in section 2.2.3.2. 
In this assay the percent of bound 125I_insulin decreased as the 
total insulin concentration increased and all data were corrected 
for non-specific binding (NSB) by subtracting the percent bound at 
10
5 
ng/mR from the percent bound at all other concentrations. The 
reason for this correction is that in the presence of a large excess 
of unlabelled hormone the specific activity of labelled hormone is 
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diluted so greatly, that statistically no labelled molecules should 
bind to specific receptors. Data were expressed as a competition 
curve by plotting percent bound versus total insulin concentration 
(ng/mi). 
2.3.3 Binding Buffer 
Initially Gavin et aI. (1973) used a Tris buffer (TBB) for their in-
sulin binding studies on IM-9 lymphocytes. This buffer contained 25 
mmol Tris (hydroxymethyl) methylamine, 120 mmol NaCI, 1,2 mmol MgS04 
2,5 mmol KCI, 10 mmol glucose, 1 mmol EDTA and 1% BSA at pH 7,6. 
Later studies on monocytes showed improved binding when HBB was used 
instead of TBB (Bar et al. J 1976; Beck-Nielsen & Pederson, 1979). 
To establish the optimal reaction buffer for insulin binding to Raji 
cells, the insulin binding assay was carried out in both TBB and HBB 
at pH 7,8. The binding assay was carried out according to the proce~ 
dure outlined in section 2.2.3.2, in the presence of increasing con-
centrations of unlabelled insulin. The % specific bound was calcula-
ted as stated in section 2.2.4. 
2.3.4 Detennination of the Ideal pH for Insulin Binding 
The specific binding of 125I-insulin to the membrane receptor is de-
pendent on the pH of the binding buffer. HBB was made up with a 
range of pH 6-9 and Raj i cells were washed 3 times in HBB of the 
appropriate pH and then resuspended in HBB with the same pH. Cells 
were then incubated with 125I-insulin (0,2 ng/mi) as previously de-
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scribed (section 2.2.3.2), in the presence or absence of 10
5 
ng/ml 
unlabelled insulin to establish maximum specific binding; % insulin 
specifically bound was plotted as a function of the pH. 
2.3.5 The Effect of Ca++ and Mg++ on Insulin Binding 
To determine whether Ca++ or Mg++ ions are necessary for the binding 
interaction, cells were washed 3 times as previously detailed in 
section 2.2.3.2 in HBB pH 8,0 containing no CaCbor MgS04. The cells 
were then resuspended in this buffer and graded concentrations of 
CaCl 2 and MgS04(O-10 mmol/l) were added to portions of these cells 
and incubated with 121-insulin in the presence or absence of 10
5
ng/ml 
unlabelled insulin. The % insulin specifically bound was plotted as 
a function of molarity of MgS0 4 and CaCI2. 
2.3.6 Time and Temperature Dependency of Insulin Binding 
Both the rate and the steady state level of insulin binding to its 
receptor depend on the temperature of the incubation. Optimum tem-
perature and time required to reach steady state binding were deter-
mined by incubation of ~25I-insulin with cells as described in sec~ 
tion 2.2.3.2 at 4°C, 15°C and 37°C for various time periods. Cells 
were incubated with 125I-insulin in the presence or absence of 105ng/ 
ml unlabelled insulin to determine NSB. The % insulin specifically 
bound at each temperature was calculated as previously described 
(section 2.2.4) and a graph of % Sp.B. as a function of time was 
plotted. 
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2.3.7 Specificity of Insulin Binding 
The receptor specificity for insulin was determined by displacement 
b d 1251 , I ' of oun -Insu In by a number of hormones with possible struc-
tural homology. These hormones included porcine proinsulin, porcine 
glucagon and porcine C-peptide which were supplied by NOVO Research 
Institute, Denmark. 
Cells were prepared as outlined in section 2.2.3.2 and then incu-
bated with 125I_insulin (0,2 ng/ml) and increasing concentrations 
(O-105ng/ ml) of C-peptide, glucagon, proinsulin and insulin. The 
incubation mixture was maintained at 15°C for 120 min. Results were 
expressed as a competition curve as described in section 2.3.2. 
2.4 RESULTS 
2.4. 1 Raj i Ce 11 Growth Curve 
Figure 2.3 represents the growth rate curve for Raji cells in cul-
ture. After splitting, the number of cells doubled within 36 hours, 
thereafter the doubling time was 24 hours. The logarithmic phase of 
growth continued for 36 hours until the stationary growth phase was 
reached 96-108 hours after splitting. Unless otherwise stated, cells 
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Measurement of the Raji cell's growth rate was 
determined by counting triplicate cell samples in a 
haemocytometer at specific time intervals. 
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2.4.2 Competition Curve 
Displacement of bound I2 )-insulin by increasing concentrations of un-
labelled insulin is shown in figure 2.4. Maximum specific binding of 
insulin to Raji cells was 7,7 ± 1,3% per 10 7 cells and non-specific 
binding was always less than 251 of total binding. The concentration 
of insulin required to displace 50% of bound hormone (10 50 ) was 3,2 
ng/m£ (5,2 x 10-10 mol/i) which indicates high affinity binding. 
2.4.3 Optimal Binding Buffer 
Maximum specific binding was higher in the presence of Hepes buffer 
as compared to Tris buffer (Figure 2.5). In addition, the ID50S for 
insulin binding in Hepes buffer and Tris buffer were 3,3 ng/m£ and 9 
ng/mi, respectively. This indicates higher affinity binding in Hepes 
buffer as a lower concentration of insulin is capable of displacing 
50% of the bound 12sl-insulin. 
2.4.4 Optimum pH 
Figure 2.6 shows the effect of pH on insulin binding to the Raji 
cells. There is a definite peak in specific insulin binding at pH 
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The competition curve between 125I-insulin (O,2ng/ml) 
and increasing concentrations of unlabelled insulin. 
Non-specific binding has been subtracted from each 
point. Individual points represent the mean and one 
standard deviation (S.D.) from two separate 





~ Hepes Buffer (ID 3,3 nglmi) 
50 








Dr. 1111111111111111.111111.11.11." ......... ". • 
"if!. 
2 







Insulin Concentration (ng/ml) 
Insulin binding to Raji cells in Hepe~ Buffer or 
Tris Buffer. Each point represents the mean of 
duplicate determinations. The IDSO for hepes buffer 






















.. , .. , .. , .. , .. 
\ 
\ 
\ . ,..-,A 
J.. ..-,,,-











'1" .• , .:r .... , .. 
7,0 8,0 9,0 
pH 
pH optimum for insulin binding to Raji cells. Each 
point is the mean of duplicate measurements. 
specific binding is obtained by subtracting non-
specific binding from total binding. 
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2.4.5 The Effect of Ca++ andMg++ on Insulin Binding 
In the concentration range 0-10 mmol/l, neither calcium nor magne-
sium ions had any significant influence on insulin binding to the 
receptor (Fig. 2.7a). However, in HBB, which normally contains 1,2 
mmol/l MgS04, increasing concentrations of calcium ions apparently 
increased specific binding of insulin t6 its receptor (Fig. 2.7b). 
2.4.6 Time and Temperature Dependence of Steady State Binding 
Steady state binding was found to be both time and temperature de-
pendent (Fig. 2.8). At 15°C maximum specific binding reached 5,5% 
after 120 min and remained at steady state until 180 min. By compa-
rison, steady state binding was reached after 30-60 min at 37°C. 
Maximum binding, however, was only 3% after 60 min and then decrea-
sed to 2% after 120 min. At 4°C a maximum of 3% specific binding 
only was reached after 24 hours. 
2.4.7 Specificity of Insulin Binding 
The specificity of insulin binding to Raji cells is demonstrated by 
the competition curve in figure 2.9. For these data, non-specific 
binding was not subtracted from total binding. Approximately 50% of 
t t I b d 125r · I o a oun -lnsu in was displaced by 10 ng/ml of unlabelled in-
sulin, whereas only 7,5% was displaced by the same concentration of 
proinsulin. No significant displacement of bound 125r_insulin occur-
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The effect of Ca and Mg ions on insulin binding 
to Raji cells. All points represent duplicate 
measurements of specific binding from two 
separate experiments. 
The effect of Ca ions on insulin binding in the 
presence of 1,2 m molll Mg 8°4 " Each point 
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Fig. 2.8 Temperature dependence of steady state binding to 
Raji cells. Non specific binding has been subtracted 
from each point, which represents the mean of 
duplicate measurements. 
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specificity of insulin binding to Raji cells is 
determined by competitive binding assays between 
radiolabelled insulin and increasing concentrations 
of unlabelled insulin, proinsulin, c-peptide and 




Based on these preliminary experiments the ideal conditions for in-
sulin binding to Raji cells have been defined. For subsequent stu-
dies of insulin-receptor binding, Raji cells were used during sta -
tionary phase, unless otherwise stated. This ensured that insulin 
receptors were not downregulated and experimental observations were 
consistent and therefore, comparable. 
The competition curve for 125I_insulin and unlabelled insulin shows 
that about 7-8% of the radioactive insulin in the incubation mixture 
was specifically bound by Raji cells. At equilibrium, 50% of this 
- 10 
bound radiolabelled hormone was displaced by 5,2 x 10 mol/£ of 
unlabelled hormone. This concentration is the same order of magni-
tude as the K d which was calculated by Scatchard analysis; th is will 
be discussed in section 3.5.1. Thus, as mentioned previously in 
section 2.2.5, the 1050 gives a reasonably accurate estimate of the 
affinity constant (K d ). 
Incubation of 125I_insulin and Raji cells in TSS and HSS showed an 
increase in the affinity of the receptor-hormone interaction in the 
latter buffer. In addition, specific binding was markedly increased 
at pH8. At lower and higher pHs insulin dissociates from the recep-
tor. Thus, incubation of cells in HBS at pH8 results in high affi-
nity insulin-receptor binding. These conditions were used in all 
insulin binding studies and they are in agreement with findings on 
both IM-9 lymphocytes and adipocytes (Sonne & Gliemann, 1980). 
It has also been demonstrated that the insulin binding requirement 
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for calcium and magnesium ions is related to ionic environment 
rather than to a dependence on specific ionic co-factors. Similar 
results have been reported for adipocytes (Cuatrecasas,1971). 
From experiments on steady state binding it was found that the ini-
tial rate of binding increased as the temperature was raised, there-
fore, steady state conditions were reached more quickly at 37°C. 
However, the amount of insulin bound at steady state was lower at 
37°C compared to 15°C. As the dissociation rate is accelerated to a 
greater degree than the association rate at higher temperatures, 
there is an overall decrease in insulin binding at 37°C (Olefsky, 
1980). Furthermore, internalization and degradation of insulin is 
increased at 37°C compared to 15°C which results in an overall de-
crease in insulin binding (these aspects of insulin-receptor func-
tion will be discussed in more detail in Chapter 4). On the basis of 
these observations, optimal conditions for steady state binding were 
defined as 120 min at 15°C. Identical conditions have been used to 
study insulin binding on human monocytes (Beck-Nielsen & Pederson, 
1979) . 
Competitive studies between bound lUI-insulin and unlabelled proin-
sulin showed some displacement of receptor bound radiolabelled in-
sulin. This suggests that there is some crossreactivity between the 
insulin receptor and proinsulin. Proinsulin is the precursor for in-
sulin and there is significant structural homology between these 
peptides: thus some interaction between proinsulin and the insulin 
receptor is indeed possible. By comparison, peptides such as C-pep-
tide and glucagon which are not structurally similar to insulin did 
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not interact with the insulin receptor. These studies have shown 
that the insulin receptor on Raji cells specifically recognises in-
sulin and insulin-like peptides. 
Previous reports of insulin receptors on cell lines derived from 
Burkitt's lymphoma have been conflicting. Initially, Gavin et aI. 
(1972) noted the absence of insulin binding to lymphocytes derived 
from Burkitt's lymphoma. A later report by Schlickenrieder et aI. 
(1985) demonstrated the presence of insulin receptors on a lympho-
cyte cell line (ALL) from Burkitt's lymphoma. 
The experimental results presented in this study have clearly de-
monstrated the presence of specific, high affinity insulin receptors 
on EB-virus transformed lymphocytes which were derived from a 
Burkitt1s lymphoma (Raji cell line). 
CHAPTER 3 
KINETIC ANALYSIS OF INSULIN BINDING TO RAJI CELLS 
Nature and Nature's Laws Lay hid in night. 
God said: "Let Newton be" and aU was Light. 
-POPE 
It did not Last. The DeviL~ shouting "Ho! 
Let Einstein be~" restored the status quo. 
-SQUIRE 
3. 1 INTRODUCTION 
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In section 1.4, the value of studying the kinetics of the binding of 
a ligand to its receptor was briefly reviewed, giving insight into 
the nature of the binding reaction. 
The purpose of the studies outlined in this chapter is to report on 
the kinetics of insulin binding to receptors on the Raji cells. As 
indicated in section 1.2.2.1, normal lymphocytes have very low 
insul in receptor numbers, but following EB vi rus transformation, 
large numbers are induced on the surface of the transformed cells. 
If it can be shown that the kinetics of insulin binding to receptors 
on the Raji cells is similar to the kinetics of insulin binding in 
other tissues, it would be reasonable to assume that the transfor-
mations induced by the EB virus result in a true expression of the 
insulin receptor gene in human lymphocytes. 
To facilitate understanding, the mathematical derivation of the gra-
phical methods for describing insulin binding to its receptors will 
be dealt with in detail before presenting the experimental evidence. 
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.3.2 MATHEMATICAL DERIVATION OF THE SCATCHARD PLOT 
In order to obtain receptor-binding constants a model for the inter-
action between receptor and ligand must be assumed or established as 
plausible. A number of mathematical models has been developed for 
the treatment of data obtained from observations on the binding of 
small molecules to macromolecules (Hill, 1909; Scatchard, 1949; Ber-
son & Yalow, 1959). Although the data from hormone-receptor binding 
studies do not often fit the idealised conditions proposed by the 
mathematical models, they do provide useful constants for describing 
the observed displacement curves. However, it is most important to 
bear in mind that the application of these mathematical analyses to 
binding assays requires a number of assumptions (Kahn et aZ.~ 1974). 
These are that: 
(i) the hormone is present as a monomer; 
(ii) the labelled and unlabelled hormones bind in an identical 
manner; 
(iii) equilibrium conditions between hormone and receptor are ob-
tained during the assay; 
(iv) bound and free hormone can be separated without perturbing 
the equilibrium; 
(v) no co-operative interactions exist between the receptors; 
(vi) the hormone-receptor binding reaction is univalent. 
If these assumptions are made in the analysis of insulin binding to 
a specific receptor, it is possible to describe the reaction by a 
series of equations derived from the Law of Mass action. 
kl 
[R] + [H] ~ [RH] 
k2 
••••••••••••• ( 1 ) 
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where H is the hormone, R is the receptor, HR is the hormone recep-
tor complex, k1 and k2 are the associati6n and dissociation rate 
constants, respectively. 
According to the Law of Mass action, the rate of formation of hor-
mone-receptor complex is dependent on the concentration of both 




•.•.......... (2) . 
The breakdown of the hormone-receptor complex is a first order reac-
tion and is given by the rate equation, 
- d [HR] 
dt 
k2 [HRl · •. .•.•. . . • .. . (3) . 
When the rate of formation of hormone-receptor complex is equal to 
its rate of breakdown, that is when the reaction system has entered 
steady state, which is defined as that state in which the concentra-
tion of HR remains constant , then 
Rearranging equation 4, 
[HR] 
[H] [R] 
• •.•.••..•••. ( 4 ) • 
· .........•.. (5 ) 
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where Ka is the equi I ibrium constant or association constant. From 
the rate equations (2) and (3) the units for kz are reciprocal time 
in seconds (S-1)and the units for k1 are reciprocal concentration 
and time (1.mol- 1.S- 1). Therefore, from equation 5 Ka would be ex-
pressed as (l.mol- 1.S- 1) or lImol that is, reciprocal molarity. 
(S 1) 
Alternatively, the equilibrium of a hormone-receptor binding reac-
tion can also be expressed in terms of the dissociation constant Kd, 
which is the reciprocal of the Ka and has the units mol/i. 
A second equation which describes the binding reaction at equili-
brium is the conservation equation of the total receptor concentra-
tion [R rJ 
[R] + [H R] = [RT] ••..••..•.... (6) . 
To obtain the Scatchard plot of Bound/Free (B/F) vs Bound (B) from 
equations (5) and (6), it is necessary to define B/F and B in the 
same terms. 
B [HR] 
F - [H] 
and bound 
B = [HR] 






Substituting for R from equation (6) 
8 Ka ([RT J ~ [8]) F 
or ............. ( 7 ) . 
8 ~ . ([RTJ - [8J) 
F d 
Equation (7) is the Scatchard plot which is commonly used to linea-
rise experimental data for graphical estimation of binding parame-
ters. A Plot of B/F vs B produces a straight line with slope -Ka and 
an intercept on the bound-axis equal to RT(Fig. 3.1a & b). A single 
class of binding sites will result in a linear Scatchard graph (Fig. 
3.1a), while non-linear plots represent two classes of independent 
binding sites which have different affinities for the ligand (Fig. 
3. 1b) . 
Determination of binding constants for curvilinear graphs is not 
straightforward. Many workers have used linear regression and extra-
polated from each half of the curve to obtain these constants. How-
ever, this approach has been criticised by Light (1984) because when 
two binding sites compete for the same pool of ligand, the high af-
finity sites bind most of the ligand at low concentrations and reach 
saturation before the second site. Therefore, to analyse the data 
correctly, the competition between the two sites must be accounted 
for mathematically. For this reason, a simple linear regression is 




Fig. 3.1 (a) Scatchard plot for ligand binding to a single 
class of independent sites (see legend overleaf). 
b 
B/F 
Fig. 3.1 (b) Scatchard plot for ligand binding to two classes 
of independent sites (see legend overleaf). 
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Fig. 3.1 (a) Scatchard plot of ligand binding to a single 
class of independent sites. 
B/ = bound/ l ' d 
F f · 19an, ree 
B = molar concentration of bound ligand, K = 
. -1 
association or equilibrium constant (l.mol ). 
RT = molar concentration of binding sites or 
binding capacity (reproduced from De Meyts and 
Roth, 1975). 
Fig. 3.1 (b) Scatchard plot of ligand binding to two classes 
of independent sites. The curve is the sum of two 
subclasses of sites, one of high affinity (K
1
), 
low capacity (RT)l' and one of low affinity (K2
), 
high capacity (RT )2 (reproduced from De Meyts and 
Roth, 1975). 
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Munson and Rodbard (1983) have developed a computer programme 
(LIGAND) which is based on non-linear or curvilinear regression. The 
data are analysed using a mathematical model relating bound concen-
tration as a function of total ligand, affinity and receptor concen-
tration. In this way the kinetic parameters which fit the experimen-
tal data can be determined. Statistical analysis of the data is done 
by weighted sum of squares and the "goodness-of-fit" . is estimated 
using the analysis of variance criterion. 
3.2.1 Scatchard Analysis of Insulin Binding Data on Raji Cells 
In this section a Scatchard plot is applied to binding data from the 
insulin competition curve previously described in section 2.4.2. The 
same data is then analysed using the LIGAND programme to determine 
the binding parameters. 
3.2.1.1 Scatchard Plot 
Data obtained from the competition curve (Section 2.4.2) were used 
to determine the ratio of bound to free (B/F) and Bound (B). These 
parameters were calculated as follows: 
7 = (mean cpm bound ~ non-specific binding) per 1D cells 
(TotaI cpm - mean cpm bound). 
Bound concentration (B*) was calculated as: 
B* (ng/ml) = (mean cpm bound - NSB) per 107 cells x Total insulin 
(nmol/~). 
A graph of B/F versus Bound (8*) nmol/~ was drawn for these data. 
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The number of receptors per cell (R~)can be calculated by the fol-
lowing equation 
R = INSULIN BOUND (mol/l) x N c 
CELL CONCENTRATION PER LITRE ..........•.. (8) 
where Insulin Bound = the intercept of the curve with the abscissa and 
023 1-
1 
N (Avogadro's number) = 6,023 x 1 mo e . 
3.2.1.2 Analysis using the Ligand Programme 
Data from the competition curve were analysed using the LIGAND pro-
gramme. The data were compared to binding models of increasing com-
plexity and the best "fit" was determined by a particular subpro-
gramme. 
After each fit a table of final parameter estimates and their stan· 
dard errors was printed as well as results from statistical analyses. 
3.2.2 Results 
A Scatchard plot for insulin binding to Raji cells is shown in 
figure 3.2. It is a typically curvilinear plot with upward concavity 
and no apparent intercept on the bound axis. 
The same insulin binding data were analysed by the LIGAND programme 
to determine the equilibrium constants and the number of binding 
sites. A printout of the computer analysis is shown in Table 3.1. 
The first two sets of parameter estimates pertain to a single bind-
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Scatchard plot for insulin binding to Raji cells. 
Insulin binding data from the competion curve 
(section 2.4.2.) were used for Scatchard analysis. 
Each point is the mean of duplicate determinations 
from two experiments. 









Parameter estimates +/_ standard error (approximate) 
K11 = O.484274E+01 +/_ O.238296E+01 
K12 = 0.438509E-02 +/_ 0.303955E-02 
R1 0.137872E-01 +/- 0.469021E-02 
R2 = 0.206094E+01 +/_ 0.138208E+01 
N1 = 0.147510E~02 +/_ 0.982176E-03 
C1 1 
SUM OF D.F. MEAN SQ F RESIDUALS 
SQUARES (+) (-) 
399.35 11 36.30432 8 8 
399.35 11 36.30432 8 8 
------------------------
SUM SQ. D.F. MEAN SQ. F 
4910.563 14 350.7545 41. 42 (P=O) 
1750.85 13 134.6808 18.61 (P=O) 
463.4102 12 38.61751 1. 76 (P= .164) 





Although non-specific binding (NSB) has been subtracted from the data 
there is still a small amount of NSB when using the two site model. 
Comparing the F value for the four "fits" it was apparent that the 5 
parameter model (fit 4) was the appropriate one. In addition, the Runs 
Test was not significant (p > 0.05) which again supports these parameter 
estimates. 
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ca 1 data ca 1 cu 1 ated by the LI GAND programme, it was cone 1 uded that 
there are two binding sites for insulin with P = 0,000 indicating 
that there is no possiblity of a single site. 
The equilibrium constants for the two sites were estimated by the 
9 -ill 
LIGAND programme to be K11 - 4,8 x 10 £/mol (K d - 2,0 x 10 mol/£) 
6 - 7 
and K - 4 39 x 10 £/mol (K
d 
- 2,3 x 10 mol/£)o 
12 ' 
Intercepts R1 (0,0138) and R2 (2 ,061) represented the intercept on 
the bound axis for equilibrium constants K11 and K12 , respectively. 
Substituting the values for R1 and R2 in equation (8) it was shown 
that R1 corresponds to approximately 2375 sites per cell and R2 to 
about 355 000 sites per cell (Table 3.2). 
3.3 PRINCIPLE OF NEGATIVE CO-OPERATIVITY 
In some polypeptide hormones such as growth hormone and prolactin, 
the Scatchard plot is linear, indicating that a single homogeneous 
class of independent binding sites is present (Lesniak et al., 1974; 
Shiu et aL, 1974). However, as was seen in the previous section, in 
the case of insulin a curvilinear plot with upward concavity is 
obtained. This phenomenon could be due to a number of factors. The 
best known examples of these are the presence of heterogeneous bind-
ing sites with different but fixed affinities, or interactions be-
tween homogeneous binding sites as in negative co-operativity. In 
the latter case the affinity of the receptors is not fixed but de-
creases with increasing receptor occupancy. Steady state data alone 
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Table 3.2. Equi I ibrium Constants for Insul in Binding to Raj i Cells 
Equilibrium constant (Ka) 
(.e/mo I) 
Dissociation constant (K d) 
(mol/i) 
Number of binding sites/cell 
BIND I NG SITE 1 
Mean (Range) 
9 
4,84 x 19 (2,6-7,2) 
-10 
2,0 x 10 (1,4-1,4) 
831 ( 548-1114 ) 
BINDING STIE 2 
Mean (Range) 
6 
4,4 x 10 (1,4-7,4) 
-7 
2,3 x 10 (1,35-7,2) 
355000 (117200-592147) 
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do not discriminate between these two models, but an eXperimental 
technique to demonstrate negative co-operativity has been developed 
(De Meyts et al. (1973). 
3.3.1 Experimental Demonstration of Negative Co~operativity 
De Meyts et al. (1973) developed an original method to demonstrate 
the presence of site-site interactions which is based on the kine-
tics of dissociation of insulin · from its receptor. The experimental 
method assumes that, in the case of negative co-operativity, the de-
t rease in receptor affinity is partially due to an increase in the 
dissociation rate. This being the case, a tracer amount of 125I_insu_ 
lin is incubated with the receptor preparation to allow low receptor 
occupancy. After steady~state interaction is achieved, the cells are 
centrifuged and resuspended in the same volume of buffer. Portions 
are then removed and lIinfinitely diluted ll (x100) in buffer (dilution 
only), or in buffer containing ~xcess unlabelled insulin (dilution + 
insulin). At various time intervals the dissociation rate is measur-
ed in both assay systems. The rationale for the presence of excess 
insulin is that unoccupied sites will be filled by unlabelled insu-
lin and the effect of receptor occupancy on the dissociation rate 
can be determined. 
Since the interpretation of results is based on changes in dissocia-
tion rate constants, it is important that no measurable rebinding of 
labelled insulin occurs during the dissociation (De Meyts & Roth, 
1975). The hormone-receptor complex which is diluted in the presence 
of insulin will have no measurable rebinding of labelled insulin 
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due to isotopic dilution of the dissociating labelled hormone. In 
the case of dilution only, no rebinding would occur if the dilution 
was truly infinite, as the free 125I-insulin concentration would be 
infinitely small and hence negligible. Although 100-fold dilution 
is not infinite, labelled hormQne concentration is initially very 
low and hence is reduced by a further two orders of magnitude. 
Indeed, De Meyts and Roth (1975) has shown that in dilutions of 
50~fold and greater, no significant rebinding of free labelled hor-
mone will occur in this experiment. 
In the case of the dilution with unlabelled insulin, the unlabelled 
hormone will bind to the unoccupied receptor sites. This should not 
influence the rate at which the tracer dissociates from the occupied 
sites unless, of course, filling of empty sites induces interactions 
between receptor sites. Hence, it should be possible by an analysis 
of insulin binding under the stated conditions, to assess whether or 
not negative co-operativity between insulin receptors plays a signi-
ficant role. 
3.3.2 Affinity Profile A Graphical Analysis 
De Meyts and Roth (1975) developed a graphical presentation of insu-
lin binding to its receptor which describes a single class of bind-
ing sites undergoing progressive site-site interactions with increa-
sing occupancy. 
The affinity of the binding sites is modified by site-site interac~ 
tions and therefore, the affinity varies as a function of occupancy 
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Because the stoichiometry of this binding process is not known, the 
concept of the "average affinity" at each level of occupancy on the 
Scatchard plot was introduced (Fig. 3.3a). The changing affinity is 
represented by the decreasing slope of the successive lines through 
the intercept R on the Scatchard plot. Thus at a particular level of 
receptor occupancy the slope of the line joining B/F to R represents 
the average affinity of the receptors. However, the actual affinity 
of the receptor is not fixed, but is distributed between two confor-
mations: a high affinity (Ke) or "empty sites" conformation and a 
low affinity (Kf) or "filled sites" conformation . 
The data from the Scatchard plot in Fig. 3.3(a) can be used to plot 
the "average affinity" profile which gives the average affinity K 
as a function of the fractional saturation Y (Fig. 3.3c). The ave-
rage affinity at each point is equal to (8/F)/(R -8) which can be 
calculated from Fig. 3.3(b). The occupancy is measured as 8/R and 
is classically designated by Y. 
From the average affinity profile four parameters K K
f 
V V 
e' , "l' f ' 
are obtained. which describe the binding system and the extent of 
site-site interactions. 
3.3.3 Measurement of Insulin Dissociation Rates to Assess Site-
Site Interactions in the Raji Cells 
3.3.3.1 The Effect of Temperature 
1~5I-Insulin (3,8 x 10~1 mol/i) was incubated with Raji cells (7,5 x 
7 
10 cells/mi) in Hepes binding buffer pH 8,0 in a total volume of 2,5 
f '" ~ 
~ E 
f! 
Filled Bj 5~ Ri = F\,-.Bi ----- B 




f 111111111111 f ' .... """""'" /II :: 
. -
B 
0.01 Ye 0.1 'if 1.0 
(Y)Fractfonal Occupancy 
Fig. 3.3 (a) 
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Scatchard Plot for 
ligand binding to a 
single class of sites 
with negative 
cooperativity. When 
occupancy increases the 
"average affinity" 
decreases from a 
limiting high affinity 




Fig. 3.3 (b) Calculation of the 
average affinity K. At 
a given point on the 
curve, i, the level of 
bound hormone, B., 
1 
corresponds to a given 
boundl = B IF .. free 1 
The value of the 
average affinity K for 
that occupancy is given 
by the negative of the 
slope - 1\ .. 
1 
Fig. 3.3 (c) The average affinity 
profile. K, the average 
affinity, calculated as 
(B/F)/(Ro - B), is 
plotted as a function 
B of log Y = log ( I
Ro
) 
(See key overleaf) 
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Fig. 3.3 (c) 
Y = 0 when all sites are empty and Y = 1 when all sites 
are occupied. 
affinity of the "empty sites" conformation K = e 
K
f 
= affinity of the "filled sites" conformation. 
Y = threshold for measurable site-site interactions. e 
Yf = fractional occupancy at which site-site interactions 
are maximal (all sites in Kf ) . 
(Reproduced from De Meyts and Roth, 1975). 
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mi for30min at 15°C. After incubation the cells were centrifuged at 
200 g for 5 min at 4°C. The supernatant was discarded and cells were 
resuspended in an equal volume of cold buffer (4°C). A portion 
(100 pi) of the incubation mixture was removed for measurement of 
bound 125I-insulin ("time zero", t = 0). Further portions (100 pi) 
were transferred to a series of test tubes which contained 10 mi of 
buffer at 15°C (dilution only). In a parallel assay 100 pi samples 
were added to 10 mi of buffer containing 1,7 x 10~mol/i unlabelled 
insulin. At various time intervals duplicate tubes from each set 
were removed and centrifuged at 200 g at 4°C. The cell pellet was 
counted in a gamma counter and radioactivity was expressed as a per-
centage of the radioactivity present at zero time. This was then 
plotted against dissociation time. 
To assess the effect of temperature on the rate of insulin dissocia-
tion in the presence and absence of unlabelled insulin, the same 
procedure was carried out at 37°C and 4°C. 
3.3.3.2 Receptor Occupancy During Dissociation 
A more direct measurement of the effect of initial receptor occu-
pancy on the dissociation of bound 125I-insulin was carried out 
according to the method of Pollet et aZ. (1977). 
The same procedure was followed using 5 x 10-g mol/i 125I-insulin to 
give high receptor occupancy and 5 x 1O- 11 mol/i'l2:5I-insulin for low 
receptor occupancy. Dissociation of bound labelled hormone was mea-
sured at 15°C in the presence or absence of 5 x 10-9 mol/f unlabel-
led insulin. This concentration was chosen so that during dissocia-
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tion, the receptor occupancy remained the same , (5 x 10-
9 
mol/.Q insu-




3.3.4.1 Dissociation Experiments 
Dissociation of unlabelled · insulin from the receptor at different 
temperatures is shown in Fig. 3.4. At 4°C, the dissociation rate 
appeared to follow first order kinetics although only 20% of bound 
12sI-insulin dissociated in 120 min. The dissociation rate at 15°C 
was slightly increased as 40% dissociated in 120 min. However, at 
this temperature the dissociation rate was no longer a first order 
reaction. When the temperature was increased to 37°C there was a 
marked acceleration in the dissociation rate (nearly 70% dissociated 
in 120 min) and the dissociation curve became multiexponential. 
A comparison of the dissociation rate in the presence or absence of 
unlabelled insulin at the same temperatures is given in Figs. 3.5a, 
band c. In all three experiments the rate of dissociation was 
increased in the presence of excess unlabelled insulin compared to 
dilution only. At 4°C (Fig. 3.5a) the amount of dissociated 12sI_insu_ 
lin increased from 20% to nearly 50%. A similar increase from 40% 
to 70% was found at 15°C (Fig. 3.5b). However, at 37°C there was 
only a 5 to 10% increase in the dissociation rate in the presence of 
excess insulin (Fig. 3.5c). 
The effect of increased receptor occupancy on the dissociation rate 
is shown in Fig. 3.6. The dissOCiation curves in the absence of 
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Mins of Dissociation 
Dissociation of membrane bound 125I-insulin at 
different temperatures. After 125r-insulin was bound 
to the receptor, the dissociation rate of labelled 
ligand was measured at 40~,150C and 37°C. All points 







80 Dilution >< only 











N II) 20 ..£ 
-'" N ... 
10 
0 20 40 60 80 100 120 
Time (mlns) 
a 15°C a .... 
100 >< 
a 80 II -g .... 
Dilution ::J -0 C\l 60 only en "0 
c C 
'§ 6 
40 II) ro Dilution & J;; ,I;; Insulin I :; 
.n- Il) 
J;; ::l 
















::: I 20 
o 20 40 60 80 100 120 
Mins of Dissociation 
----_~ Dilution 
only 
DWtion .~----+- & 
Insulin 
10~------r---~-----r----~--~r----.------~ 
o 20 40 60 80 
Time (mins) 
100 120 
The effect of unlabelled insulin on the dissociation 




The effect of unlabelled insulin on the dissociation 
of 12SI-insulin at 4° C, 15°C and 37° C. In these 
experiments the dissociation of radiolabelled 
insulin was measured in the absence (dilution only) 
-7 or presence (dilution + insulin) of 1,7 x 10 moljl 
unlabelled insulin. Each point is the mean of 
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20 30 40 50 60 
Mins of Dissociation 
Receptor occupancy does not affect dissociation of 
b d 125 , I' h oun I-~nsu ~n. T e d · . t' f 125 . l' lSSOCla lon 0 I-lnsu ln 
-11 -9 
(5 x 10 and 5 x 10 mol/l) was measured in the 
absence of unlabelled insulin (dilution only) and in 
the presence of 5 x 10-9 molll unlabelled insulin. 
This concentration of insulin resulted in an increase 
. -11-9 ln receptor occupancy (5 x 10 to 5 x 10 molll 
insulih) or constant receptor occupancy (5 x 10-9 
molll insulin). All values represent the mean and one 
S.D. of duplicate measurements. 
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unlabelled insulin (dilution only) are the same for both high and 
low binding site occupancy (5 x 10-
9 
mol/£. and 5 x 10-
11 
mol/£. 125 1_ 
insulin, respectively). 
In the presence of 5 x 10-
9 
mol/£. unlabelled insulin the dissocia-
tion rate increased equally for both concentrations of 125 I-insulin. 
At high receptor occupancy (5 x 10-9 mol/£. 125I-insulin) thedissoci-
ation of labelled hormone was increased in the presence of unlabelled 
insulin although the receptor occupancy remained the same. 
3.3.4.2 Graphical Analysis 
A plot of the average affinity versus fractional occupation for the 
Raji cells is given in Fig. 3.7. The high affinity sites (Ke) repre-
sented 1 to 1,3% of the total number of receptors and this percen-
tage of receptors represented the threshold for measurable site-site 
interactions (Te ). After 30 to 35% receptor occupancy, the site-sit~ 
interactions were maximal and a limiting low affinity (Kf) was 
obtained. 
3.4 DISCUSSION 
Curvilinear regression analysis using the LIGAND programme, showed 
that insulin binding data on Raji cells fits a two-site model. A 
relatively small number of sites bind insulin with a high affinity, 
whereas the majority of the binding sites appear to have a lower 
























0,1 Yf 1,0 '. 
Fractional Occupancy (9) 
The average affinity profile of insulin binding to 
Raji cells. K = affinity of the "empty sites" e 
conformation, Kf = affinity of the "filled sites" 
conformation, Ye = threshold for measurable 
site-site and Yf = fractional occupancy at which 
site-site inte~actions are maximal. This plot is 
computed from the Scatched plot and therefore the 
parameters used to describe insulin binding are 
further removed from the primary data. 
sr 
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The Kd for the high affinity insulin binding site on Raji cells was 
similar to published data on liver membranes, isolated adipocytes 
and IM-9 lymphocytes (Hammond et aL., 1972; Kahn et aL., 1974 and 
Pollet et aL., 1977). However, the lower affinity Kd was about two 
orders of magnitude greater than published data on the same tissues, 
while the total number of sites per cell was ten times higher. The 
reason for this discrepancy was, probably, because binding data for 
the Raji cells was determined over a wider range of insulin concen-
trations which enabled more accurate determination of these con-
stants (Klotz, 1982; Light, 1984). Using a novel method for deter-
mining binding constants, Pang and Schafer (1984) have demonstrated 
- .10 
high affinity (Kd -6 x 10 mol/i) and low affinity dissociation con-
-7 
stants (Kd -0,8 x 10 mol/i) for purified insulin receptors from 
human placenta which are similar to those reported here for Raji 
cells. 
Dissociation of insulin from its receptor at 4°C followed first 
order kinetics suggesting that at low temperatures the conformation 
of binding sites is homogeneous. At higher temperatures however, dis-
sociation was multi-exponential and implied heterogeneity of binding 
sites or interaction between binding sites. De Meyts et a~ (1976) 
have argued that first order dissociation at 4°C precludes pre-
existing heterogeneity of binding sites and favours site-site 
interactions. 
Experimental evidence from the Raji cells showed that the rate of 
125~insulin dissociation from occupied sites was increased by fil-
ling empty receptor sites with unlabelled insulin. Acceleration of 
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the dissociation rate by increasing receptor occupancy has been 
interpreted as evidence for site-site interactions of a negatively 
co-operat i ve nature (De Meyts et aL ~ 1973). 
Based on this phenomenon, De Meyts et a1., 1976 proposed a model in 
which the receptor sites can exist reversibly in either a slow dis-
sociating or a fast dissociating conformational state. As the number 
of occupied sites increases they are able to undergo a transition 
from the slow dissociating state to a fast dissociating state. This 
transition is also facilitated by temperature. 
In Raji cells the difference between the dissociation rate of bound 
125 I-insulin at low receptor occupancy (dilution only) and when the 
sites are filled (dilution + insulin) is decreased at 37°C compared 
to 15°C and 4°C. This implies that the interaction between receptors 
is decreased at physiological temperatures. However, it has been 
suggested that at low receptor occupancy the increase in temperature 
represents the energy necessary to shift receptors from the slow 
dissociating state to the fast dissociating state. The nature of 
this transition from one state to another is considered to be a con-
formation change in individual receptor subunits or clustering of 
receptors in the fluid membrane, or a combination of both (De Meyts 
et al. 1976). Support for the existence of different conformational 
states has recently been demonstrated with monoclonal antibodies to 
the insulin receptor. Two monoclonal antibodies which compete with 
insulin for the same binding site increase the rate of dissociation 
of bound ligand and appear to stabilize the low affinity fast disso-
ciating conformation state (Forsayeth et al. 1987). On the other 
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hand, two different monoclonal antibodies which precipitate the re-
ceptor but do not compete with insulin seem to favour the high affi-
nity slowly dissociating state of the insulin receptor (Gu et aZ. 
1988). 
The interpretation of the kinetics of insulin binding to its recep-
tor on the basis of negative co-operativity was challenged by Pollet 
et aZ. (1977). These authors demonstrated that the dissociation rate 
of 125I_insulin from IM-9 lymphocytes was not dependent on receptor 
occupancy. Results of the current studies on the Raji cells have 
shown that the increase in the dissociation rate is unchanged at high 
receptor occupancy and when receptor occupancy is kept constant. 
Thus, the increased dissociation rate in these cells is not directly 
related to receptor occupancy. 
To date, the experimental methods of differentiating between the 
negative co-operativity model and the two-site binding model have 
been inconclusive. 
Recently a new receptor model was proposed based on experimental 
evidence from double probe labelling (Pang & Schafer, 1984). It was 
found that a single receptor unit bound two insulin molecules but, 
the two binding sites had markedly different affinities for insulin. 
Negatively co-operative interactions between the two binding sites 
could account for the observed increase in dissociation of bound 
insulin in the presence of unlabelled insulin. Thus, the curvilinear 
nature of the Scatchard plot might result from both receptor hetero-
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geneity and negative co-operativity which are intrinsic to the insu-
lin receptor structure. 
As discussed earlier (section 1.5.2), structural studies on the 
insulin receptor have shown that the membrane receptor is bivalent. 
This would enable the receptor to bind two insulin molecules. These 
observations appear to support the insulin receptor model proposed 
by Pang & Schafer ( 1984). 
If the insulin receptor is bivalent and these two binding sites in-
teract with one another, then two of the assumptions made in section 
3.2 are no longer valid. Consequently, the binding constants derived 
from Scatchard analysis would have no precise physico-chemical mean-
ing. Despite the apparent ambiguities in this receptor model, these 
binding constants have been useful in comparative studies on differ-
ent tissues and in disease states where insulin binding to its re-
ceptbr is impaired. 
Clearly, the LIGAND programme provides a sophisticated tool for 
analysing insulin binding data. Although the kinetic and structural 
data suggest that the traditional mathematical models are inadequate 
for analysing insulin binding, the LIGAND programme has the advan-
tage of giving consistent results on kinetic stUdies. 
Analysis of the kinetics of insulin binding to whole cells is fur-
ther complicated by the presence of insulin-like growth factor 
receptors which appear to bind insulin with a lower affinity. The 




Quantitative analysis of insulin binding data on the Raji cells sug-
gested the presence of heterogeneous sites with similar kinetic con-
stants to those reported by Pang & Schafer (1984). 
However, the average affinity profile for insulin binding to Raji 
cells was similar to data reported by De Meyts & Roth (1975) in sup-
port of the negative co-operativity model. The rate of dissociation 
was increased in the presence of insulin, although this did not 
appear to be dependent on receptor occupancy. In addition, there was 
some evidence that increased temperature induced a change in the 
conformation of the receptor. 
From the information presented here the insulin receptor on the Raji 
cells is best described by the model proposed by Pang & Schafer 
(1984). This model incorporates both receptor heterogeneity and site 
-site interactions which could induce different conformational 
states. 
CHAPTER 4 
ENDOCYTOSIS OF INSULIN AND THE MEMBRANE RECEPTOR IN RAJI CELLS 
An Qrganic beings originate from and consist of vesicLes 
or cells. These~ when detached~ and regarded in their 
original process of production~ are the infUsorial mass 
or prilTl3val slilTl3 whence all larger organisms fashion 




Having established that the kinetics of insulin binding to Raji 
cells is similar to published data on both target tissue and non-
target tissue, the functional aspects of insulin binding to its 
receptor were investigated. 
As mentioned in section 1.6.2, morphological studies have shown 
that once insulin has bound to its receptor, the insulin-receptor 
complex is internalised by the process of endocytosis. The inter-
nalised complex is then associated with a number of intracellular 
vesicles; dissociation of insulin from the receptor probably occurs 
in the endosome. Carpentier et al. (1986) have suggested that this 
dissociation might be the first step in receptor recycling and, in 
some cell types, the dissociated insulin is subsequently degfaded 
intracellularly in the lysosames. At present, it appears that endo-
cytosisof the insulin-receptor complex is a mechanism to remove 
the hormone from the cell surface and terminate its signal. Impor-
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tant functional consequences of this process would appear to be 
hormone i nterna 1 i sat ion fo llowed by a loss of membrane receptors, a 
process known as downregulation. 
In this chapter, internalisation of radiolabelled insulin and insu-
lin-induced receptor downregulation have been studied in the Raji 
cell, using well established biochemical techniques. 
125 
4.2 MEASUREMENT OF I-INSULIN INTERNALISATION BY RAJI CELLS 
4.2.1 Principle of the Experimental Method 
Previous studies have demonstrated that mild acid treatment of 
cells can be used to rapidly strip off about 90% of cell surface 
receptor-bound hormone while removing less than 10% of the interna-
lised hormone (Haigler et aL., 1980; Shimizu et aL., 1981). In this 
experiment, internalisation of insulin into the Raji cells is de-
monstrated by exploiting this simple finding. Cells incubated with 
125 . 
I-Insulin are harvested after various time intervals and the re-
lative amounts of 12~-insulin remaining in the cell after acid 
treatment or similar treatment in buffer can be measured. Hence, 
the relative amount of 
125 
I-insulin internalised by the cell can be 
calculated. By carrying out the experiments at various temperatures 
it is possible to reach conclusions concerning the energy depen-
dence of the internalisation process. 
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4.2.2 Materials and Methods 
In this experiment Raji cells were grown as previously described in 
section 2.2.2.2 and were used during the stationary phase of growth 
6 
at a density of 1-2 x 10 cells/mR. The chemical composition of 
Hepes binding buffer (HBB) was previously described in section 
2.2.3.1. A mild acetic acid solution (MAAS) consisting of 0,2 mol/R 
acetic acid (pH 2,5) and 0,5 mol/R NaCI was used to remove cell-
125 
surface bound I-insulin. 
4.2.3 Procedure 
After washing and resuspending the cells in HBB, 400 pR portions 
were incubated in a series of test tubes with 0,6 ng/mR (1 x 10 
-10 
mol/R)LUI-insulin in 50 pR, in the presence or absence of 10 5 ng/mR 
~ 5 
(1 x 10 mol/R) of unlabelled insulin. Incubations were carried 
out at 37°C, 15°C and 4°C. 
At various time intervals, duplicate 200 pi portions of the incuba-
tion mixture wer~ removed and layered onto an equal volume of HBB 
at 4°C, followed by centrifugation at 200 g for 5 min. The cells 
were washed three times with 500 pi of HBB and wer~ then treated 
with 700 pi of MAAS at 4°C. After 6 min the cells were centrifuged 
at 200 g for 5 min. The supernatant was discarded and the cell pel-
let wa~ washed with another 500 pR MAAS. Once again the supernatant 
was discarded and the cell pellet was counted in a Berthold gamma 
counter as described in section 2.2.3.2. 
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A control study was carried out in a parallel series of test tubes, 
with HBS being substituted for MAAS. The amount of radiolabelled 
insulin which was internalised (MAAS treated) was expressed as a 
percentage of insulin associated with HBS treated cells and presen-
ted graphically by plotting against time. 
4.2.4 Results 
l25 
A time course of I-insulin internalisation by Raji cells at 37°C 
15°C and 4°C is presented in fig. 4.1. At all three temperatures 
l25 
I-insulin was internalised most rapidly in the first 30 min and 
thereafter reached a plateau. However, at 37°C approximately 90% of 
l25 
the I-insulin was taken up by the cells, whereas at 15°C and 4°C 
only 40-50% of the radiolabelled hormone was internalised. 
4.3 MEASUREMENT OF INSULIN-INDUCED LOSS OF RECEPTORS (DOWNREGULATION) 
4.3.1 Principle of the Experimental Method 
Raji cells are pre-incubated with unlabelled insulin in the first 
instance in order to downregulate the number of insulin binding 
sites. Following on this, insulin which is bound to the receptor is 
removed by incubating cells in a PBS buffer pH 6 at 30°C. This pro-
cedure promotes dissociation of endogenous insulin bound to the 
receptor without damaging the membrane receptor (Kosmakos & Roth, 
1980). This mild treatment which promotes dissociation of receptor 
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Time (mins) 
The effect of temperature on interna1isation of 
membrane bound insulin. At specific time intervals 
the amount of acid resistant cell-associated 
125 '1' d t ' d t f b d I-lnsu In was e ermlne as a percen age a oun 
radiolabelled hormone. Each point represents the mean 
and one S.D. of duplicate measurements from two 
similar experiments. 
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unoccupied receptor sites remaining on the cell surface. Insulin 
binding studies are then carried out in the normal way as described 
in section 2.2.3 and the results compared with Raji cells which 
were carried through the same procedure, but not exposed to insulin. 
A diagramatic presentation of the principle on which the procedures 
are based is set out in Fig. 4.2. 
4.3.2 Materials and Methods 
As previously mentioned in section 2.2.2.2, Raji cells were used 
during stationary growth phase. All procedures, except the insulin 
binding assay, were carried out under sterile conditions. The com-
position of HBB was previously described in section 2.2.3. 1. Phos~ 
phate buffered saline (PBS) pH 6,0 contained 0,07 mol/INa~P04' 
0,07 mol/I Na 2 HP04, 0,325 mol/I NaCI and 0,1% BSA. 
4.3.3 Procedure 
Raji cells were removed from RPMI-1640 medium by centrifugation at 
200 g for 5 mi n and then resuspended in an equa I vo I ume of fresh 
growth medium. Equal portions (60 ml) were transferred to three 
culture flasks and insulin was added to two of the flasks at con-
centtations of 1 x 10-~ mol/I and 1 x 16 6 mol/I. The third flask, 
without added insulin, served as a control. Series of flasks were 
incubated for varying time intervals ranging from 0-24 hours at 
37°C in an atmdsphere of 5% CO 2 and 95% air. On completion of the 
incubation period, 5 mi portions of cells were pelleted by centri-
fugation at 200 g for 5 min. To dissociate endogenous insulin bound 
Cell density 1-2 x 10 6 cells/mf 
3-4 days after feeding 
~200 g for 5 min 




10- 8 mol/f Insulin 
1 
10- 6 mol/f Insulin 
I 
Fig. 4.2 
Incubate at 37°C for 0-24 hr 
cf200 g for 5 min 
I 
Wash duplicate 5 mf portions 3 times with 
15 mf PBS, pH 6 with 0,1% BSA at 30°C 
t200 g for 5 min 
Resuspend cells in binding buffer 
and carry out insulin binding assay 
The experimental procedure for measurement of down-
regulation of insulin receptors by addition of exo-
genous insulin to the Raji cell medium 
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to the receptors, cells were washed in 15 ml PBS pH 6 at 30°C and 
then centrifuged at 200g for 5 min. Cells were then incubated for 
25 min at 30°C in the same volume of PBS and re-centrifuged. This 
procedure was carried out twice. After the washing procedure cells 
were resuspended in 5 ml HBB and the insulin binding assay was car-
ried out as described in section 2.2.3. 
4.3.4 Calculations 
The amount of insulin specifically bound to the cells immediately 
before addition of exogenous insulin (zero time, t = 0) was taken 
as maximum specific insulin binding. The results of insulin binding 
after pre-incubation of cells with insulin at various time inter-
vals (t = n) were expressed as a percentage of this value. 
cpm-NSB at t = n x 100 
cpm-NSB at t = o. 
These results are presented graphically as a plot of % 




Fig. 4.3a showS the dose-response of pre-incubating Raji cells with 
unlabelled insulin and subsequent measurement of specific insulin 
binding. At t = 0, 7,85% ± 0.24 of 125I_insulin was specifically 
bound to the cells. After only two hours pre-incubation there was 
about a 15% decrease in receptors in the control. By comparison, 
pre-incubation of cells with 1 x 10-8 mol/l and 1 x 10- 6 mol/l 
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Fig. 4.3 (a) Loss of membrane receptors after 1-4 hours 
incubation with exogenous insulin. 
(b) Downregulation after 1-24 hours pre-incubation 
with exogenous insulin (see legend overleaf) . 
Fig. 4.3 
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Loss of membrance receptors after 1-4 hours (a) and 
1-24 hours (b) pre~incubation with exogenous insulin. 
The experimental details have been outlined in detail 
in fig. 4.2. All points in (a) are the mean of 
duplicate determinations. In (b) each point lS the 
mean and one S.D. of two separate experiments. 
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In all cases receptor loss reached a nadir after about 4 hours and 
this level was maintained for 24 hours. During this period receptor 
loss in the control was 35-40%. For this same period, both 1 x 10-
8 
mol/Q and 1 x 10-6 mol/Q insulin induced an 80% loss in receptors. 
There was no significant difference in receptor decrease between 
these insulin concentrations (Fig. 4.3b). 
4.4 DISCUSSION 
Results of the internalisation studies showed that after binding to 
the receptor, insulin was rapidly taken up by the Raji cells. The 
initial rate of insulin internalisation was time-dependent. However, 
after 30 min a steady state was reached. Establishment of an equi-
librium between insulin binding and internalisation after 30 min 
was common to all three temperatures studied. At the more physiolo-
gical temperature the initial rate of internalisation was increased 
compared to 4°C and 15°C. In addition, the amount of insulin inter-
nalised at 37°C was greater than that at lower temperatures. By 
contrast, there was no apparent difference in the rate and amount 
of insulin internalised at 4°C and 15°C. These observations suggest 
that the movement of insulin into the cell is not via simple diffu-
sion, but by an energy-dependent, metabolic process. This is in 
agreement with previous studies which have shown that endocytosis 
is inhibited by treatment of cells with metabolic pOisons which 
decrease cellular ATP levels (Steinmann et aL, 1974). 
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The meChanism of insulin internalisation in the Raji cells is pro-
bably receptor-mediated. Indirect evidence of this mechanism is that 
pre-incubation of Raji cells with insulin, induced an 80% membrane 
receptor loss after 24hr while a loss of only 30-40% of membrane 
receptors was shown in the control after the same period. This 
decrease of receptors in the control study was probably due to the 
presence of insulin in FCS in the fresh medium which was added to 
the cells at the beginning of this experiment (about 3,5 x 10-
10 
mol 
/1 insulin). Thus the control experiment may, in fact, be interpre-
ted if not entirely, then certainly in part, as an indication of 
the receptor loss induced by 3,5 x 10
JO 
mol/1 insulin. 
In both the control incubations, and in cells exposed to exogenous 
insulin, there was an initial rapid loss in the number of receptors 
until a new steady state set in. The initial rate of receptor loss 
was directly related to the concentration of exogenous insulin. In 
addition, after 4 hrs the new state of equilibrium between insulin 
binding and receptor concentration was higher in the control incu-
bation than in the incubations in which insulin was added, which 
further suggests that receptor loss is related to insulin levels. 
However, after 4 hrs pre-incubation there appeared to be a nadir 
8 
steady state at 10- mol/l insulin beyond which increasing concen-
trations of insulin did not decrease receptor number. Despite a 
100-fold increase in insulin concentration (10- 6 mol/1), receptor 
number did not decrease further than 70-80%. These findings are 
consistent with the results of other workers who have shown that 
18 hr exposure of human adipocytes and monocytes to physiological 
concentrations of insulin (10- 1 °_ 10-9 mol/i) induced an 80% de-
100 
crease in receptor numbers (Schimke, 1975; Bar et aI., 1976). In 
cultured human lymphocytes (IM-9), a similar decrease in insulin 
receptors was induced by 10- 6 mol/Q insulin (Kosmakos & Roth, 1980). 
It would seem Raji cells are slightly less sensitive to insulin 
than adipocytes and monocytes, but are more sensitive than cultured 
human lymphocytes (IM-9). 
Although these experiments have shown that both the hormone and 
receptor were initially internalised in a time-dependent manner, 
both processes eventually reached saturation and a new steady state 
was established. 
So far it has been difficult to establish a direct relationship 
between hormone internalisation and receptor downregulation as it 
has been shown that the receptor can rapidly be re-cycled back to 
the cell membrane (Carpentier et aI., 1984). It can be speculated 
that the remaining 20-30% insulin binding which was not lost fol-
lowing pre-incubation with high concentrations of insulin repre-
sents the amount of receptor which was recycled. 
As both the hormone and receptor are internalised, it is clear that 
this process plays an important role in removing insulin from the 
cell surface and regulating the membrane receptor concentration. 
Since this mechanism of receptor regulation has been demonstrated 
in the Raji cells it would seem that the virus-induced insulin re-
ceptor is functionally competent in the physiological sense. In 
addition, downregulation of the receptor occurred at relatively low 
insulin levels which suggests that this cell line is sensitive to 
physiological insulin concentrations. 
CHAPTER 5 
INSULIN DEGRADATION BY RAJI CELLS 
"The biochemist strives to obtain a mental picture of 
that invisible dance and transforTTrltion of molecules 




In Chapter 1 (section 1.6.2.2) the significance of intracellular 
insulin degradation was discussed, and in the previous chapter, the 
. process of insulin internalisation was demonstrated in Raji cells . 
At present, receptor-mediated degradation of insulin is thought to 
be the primary physiological process for termination of insulin ac-
tion. However, measurement of this pathway in an in vitro system 
such as a cultured cell line, is not straightforward. At least 
three sites of insulin degradation have been identified. Firstly, 
non-specific degradation of insulin by extracellular proteases in 
the cell medium (Sonne & Gliemann, 1980). Secondly, degradation 
. of insulin by specific cell surface proteases (Yokono et aI., 1982) 
and thirdly, as mentioned previously in section 1.6.2.2, insulin 
can be internalised by the cell and eventually be degraded intra-
cellularly in the lysosomes. In the latter case, the degradative 
products of lysosomal insulin degradation are rapidly extruded by 
the cell into the surrounding medium. 
-
1~ 
As the proteolytic products of all three degradative pathways are 
found in the extracellular medium it is difficult to distinguish 
the contribution of each process to overall degradation. 
In this chapter, all three mechanisms of 125I-insulin degradation by 
Raji cells have been investigated, using a series of independent 
biochemical techniques. 
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5.2 DEGRADATION OF I-INSULIN BY EXTRACELLULAR PROTEASES 
5.2.1 Principle of the Method 
Studies on 125I-insulin degradation by extracellular proteases were 
carried out according to the methods of Sonne & Gliemann (1980). 
The amount of labelled insulin degraded after incubation in the 
medium was determined by precipitation of incubation medium with 
cold trichloroacetic acid (TCA). In dilute solution, TCA denatures 
and precipitates both large proteins and short oligopeptides. As 
free amino acids are soluble in TCA, the measurement of the degra-
dative product iodotyrosyl, can be used to quantitate insulin 
degradation. A schematic presentation of the experimental procedure 
is given in figure 5.1. 
5.2.2 Materials and Methods 
HBB was previously described in section 2.2.3.1. Radiolabelled in-
sulin and unlabelled insulin were described earlier (section 2.2.1). 
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Raji cells (1 x 10 7 cells/mil were washed three times and then re-
suspended in HB8 pH 8,0 as detailed in section 2.2.3.2. Two equal 
volumes (60 mi) of cells were then pre-incubated at 37°C for 30 
min. In order to determine whether proteases were released by the 
cells into the surrounding medium during this 30 min incubation, 
cells from one of the incubation mixtures were removed by centrifu-
gation at 200gfor 5 min. Portions (400 ~£) of the cell-free medium 
were then incubated with 0,6 ng/mi 125I-insulin (1 x 10-10 mol/i) in 
the presence or absence of 10 ng/mi unlabelled insulin. In a paral-
lel series, 400 ~i portions of the second incubation mixture con-
taining cells were incubated with 1251-insulin. This cell incubate 
represented total insulin degradation from all three sites previous-
ly described (section 5.1). By comparing the degradation of 125 1_in_ 
sulin in these two incubates, it was possible to determine the re-
lative contribution of extracellular proteases to total degradation. 
After various time intervals, duplicate portions (200 ~i) from each 
incubation mixture were removed and added to an equal volume of 
ice-cold 25% TCA. Samples were kept on ice and then centrifuged at 
4°C in a Beckman microfuge. The supernatant was removed and radio-
activity in both the supernatant and the pellet was counted in the 
Berthold gamma counter. 
The amount of 1251-insulin which was soluble in TCA was expressed as 
a percentage of total counts in the incubation mixture. Degradation 
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f
12S I ' l' o . ~Insu In in the presence of a large excess of unlabelled 
insulin was taken as non-specific degradation. 
This experiment was repeated at 15 °C to determine the amount of 
degradation which occurs during the steady state binding assay 
(section 2.4.2). 
5.2.4 Results 
Degradation of 125I_insulin after 120 min at 37°C in the presence of 
cells and in the cell-free medium reached 9,5% and 14%, respec-
tively (Fig. 5.2a). At 15°C (Fig 5.2b) cell degradation of insulin 
decreased to 4,5% and degradation of insulin by cell-free medium 
was 3%. Thus, compared to 37°C, the amount of insulin degraded by 
the cells at 15°C was greater than that degraded by the extracel-
lular proteases. 
5.3 RECEPTOR-MEDIATED DEGRADATION OF 12;5 I-INSULIN 
5.3.1 Principle of the Method 
The possible correlation between 12sI-insulin binding to the recep-
tor and degradation of labelled hormone by the Raji cells was in-
vestigated using the method of Taylor SI,(personal communication). 
This technique relies on the consideration that, if insulin binding 
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Fig. 5.2(a) Degradation of 125r-insUlin by extracellular 
proteases at 37oC~ The relative amount of TeA 
soluble iodotyrosyl from extracellular proteases 
(media degradation) and cellular degradation was 
determined as outlined in figure 5.1. Degradation 
in the presence of unlabelled insulin was 
subtracted at each point to give specific 





C\I - Specific cell rw (J) 7 degradation -11-coz 









30 60 90 120 150 180 
TIME (min) 
. (b) d t' f 125 . I' b . t 11 1 Flg. 5.2 Degra a ~on 0 I-~nsu ~n y ex race u ar 
proteases at 150 C. Degradation of 125I-insulin by 
extracellular proteases and cellular degradation 
was determined by measuring TeA soluble 
iodotyrosyl at specific time intervals. 
Degradation of radiolabelled insulin in the 
presence o£ unlabelled insulin was less than 0,1% 
and has been subtracted from the data to give 
specific degradation. ~ach point is the mean of 
duplicate measurements. 
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labelled insulin under steady state binding conditions must de-
crease progressively when increasing concentrations of unlabelled 
hormone are added to the incubation mixture. Specificity of the 
degradative process can be defined if labelled glucagon, which does 
not bind to the insulin receptor, is substituted for labelled insu-
lin. If the degradation is specific for insulin bound to its recep-
tor, then increasing concentrations of unlabelled insulin should 
not affect the glucagon degradation. 
5.3.2 Materials and Methods 
HSS was described in section 2.2.3.1. Details of radiolabelled in-
sulin and unlabelled insulin were previously mentioned in section 
2.2.1. (3-[ 125 Il-iodotyrosytO) glucagon was obtained from Amersham, 
UK. 
5.3.3 Procedure 
In this experiment 0,28 ng/mi 1251-glucagon (7,6 x 1O-"1l moi/.Q) and 
1251-insulin (5 x 10-
11
mo.Q/.Q) were incubated with Raji cells (1 x 
10
1 
cells/m.Q) in HSS pH 8,0 at 15°C. Increasing concentrations of 
unlabelled insulin (0-10
5
ng/m.Q) were added to the incubation medium 
in both studies. After 120 min at 15°C the amount of hormone degra-
ded was determined by preCipitating the incubation medium (200 p.Q) 
with an equal volume of 25% TCA as described in section 5.2.1. The 
TCA soluble radioactivity in the absence of unlabelled hormone was 
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considered maximal degradation and results were expressed as a 
percentage of maximal degradation. 
5.3.4 Results 
125 125 
Degradation of I-insulin and I-glucagon in the presence of in~ 
creasing concentrations of unlabelled insulin is shown in Fig. 5.3. 
Maximal degradation of insulin and glucagon was 24,1% ± 0,28 and 
65,05% ± 0,49, respectively. In the range 10 - 105 ng/ml of unla-
belled insulin the degradation of 125I_insulin was inhibited by 
about 80%. 12~· By comparison the degradation of I-glucagon was not 
affected by this concentration of unlabelled insulin. 
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5.4 DETERMINATION OF CELL SURFACE AND INTRACELLULAR I-INSULIN DEGRA-
DATION BY GEL FILT~TION 
5.4.1 Principle of the Method 
To determine whether cell surface bound and internalised insulin 
was intact or degraded, the cells were incubated with 125I_insulin 
and then subjected to a mild acid wash. As described in the pre-
vious chapter (section 4.2.1), MAAS can be used to extract cell-
surface bound 125I-insulin leaving behind intracellular radiolabel-
led hormone. Exactly the same procedure was carried out for this 
experiment, except the relative amounts of extractable and non-
110 
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The relationship between insulin binding and insulin 
degradation. The effect of increasing concentrations 
of unlabelled insulin on 125I-insulin and 
125I-glucagon degradation, was determined after 
steady state binding at 15°C. Degradation of both 
radiolabelled hormones in the absence of unlabelled 
hormone was taken as maximal. Each point represents 
the mean of duplicate determinations. 
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extractable radioactivities were determined by gel filtration. 
S.4.2 Materials and Methods 
Gel filtration was carried out on a Sephadex G-SO column (1,S x 90 
cm) which was pre-equilibrated with the elution buffer, 0,1% (w/v) 
BSA in O,S mol/R acetic acid (Sonne & Gliemann, 1980). The flow 
rate of the column was 64 mR/hr and fractions were collected at 3 
min intervals. 125I_insulin (20 000 cpm) was applied to the column 
to determine the elution volume (Ve) of intact insulin, and the 
void volume (Va) was determined using the elution volume of dextran 
blue. 
S.4.3 Procedure 
Raji cells were washed 3 times as described in section 2.2.3.2. 
The cells (10 7 cells/mR) were then incubated with 1 ng/mR 125I_insu_ 
lin in HBB for 60 min at 37°C. After incubation cells were centri-
fuged at 200 g for S min and washed twice with HBB to remove free 
125. . I-InsulIn. Radiolabelled insulin bound to the cell surface was 
extracted with MAAS as described in section 4.2.1 and the acid ex-
tract was layered on to the Sephadex G-SO column. The cell pellet 
was dissolved in 6 mol/! urea, 3 mol/! acetic acid and 0,1% triton 
X-100 and then centrifuged at 400g for S min to remove cell debris. 
The supernatant from the solubilised cells was removed and placed 
on the Sephadex G-SO column. Fractions were collected and radioac-
tivity was counted in a Berthold gamma counter. In addition, SOOp! 
portions from each fraction in the radioactive peaks were removed 
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and precipitated with 25% TCA as described in section 5.2.1. The 
relative amounts of radioactivity soluble or insoluble in TCA were 
used as an indication of insulin degradation. 
5.4.4 Results 
The void volume (Vo) of the column as determined by dextran blue 
was 75 m1 and the elution volume (Ve) of 125I_insulin was about 147 
m1 (Fig. 5.4a and b). From the column dimensions the total volume 
was estimated as about 159 m1. 
Radiolabelled insulin, which was removed from the cell surface with 
MAAS and then subjected to gel-filtration, demonstrated two peaks 
(I and II, Fig. 5.4a). Peak I eluted at the same volume as intact 
125I_insulin. By contrast, peak II eluted after the total volume of 
the column and most of the radioactivity was found in this peak. 
As mentioned previously in section 5.2.1, iodotyrosyl is the insu-
lin degradation product which is soluble in TCA. From Fig. 5.4a, it 
appears that portions of peak I contained no TCA soluble material, 
whereas the portions (500U 1) taken from fractions in peak II con-
sisted of about 95% TCA soluble material. 
The intracellular radioactivity comprised three peaks on gel fil-
tration (Fig. 5.4b). The first peak (I) eluted at the void column, 
125 
peak II eluted with intact · I-insulin and peak III eluted after the 
total column volume. There was a slight shoulder to the right of 
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Fig. 5.4 (a) Gel filt~ation of cell surface bound 125I-insulin. 
Radiolabelled insulin bound to cell surface 
receptors after 1 hour incubation was dissociated 
with a mild acid wash and then subjected to gel 
filtration on a sephadex G-50 column. The closed 
circles represent total radioactivity in the 
fractions and open circles correspond to the 
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Fig. 5.4 (b) Intracellular 125I-insulin was determined by gel 
filtration of solubilised cell extracts. After 
dissociation of surface bound radiolabelled 
insulin the cells were solubilised and then 
applied to a sephadex G~50 column as described in 
the text. Radioactivity in the fractions is shown 
by closed circles and open circles represent TeA 
soluble radioactivity. 
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Peak II , which represents intact 125I-insulin, had no TCA soluble 
material. Portions of the third peak, however, contained only TCA 
soluble material. 
5.5 LYSOSOMAL DEGRADATION OF 125I_INSULIN 
5.5.1 Principle of the Method 
As previously mentioned in section 1.6.2.2, pre-treatment of adipo-
cytes with chloroquine, inhibits lysosomal degradation of insulin, 
resulting in an increase of cell-associated (intact) 125 I-insulin 
(Olefskyet al., 1982). 
5.5.2 Materials and Methods 
Chloroquine disulphate was purchased from Sigma Chemicals, USA. 
HBB was described in section 2.2.1. 
Details of 'l:25I-insulin and unlabelled insulin were given in section 
2.2. 1. 
5.5.3 Procedure 
To demonstrate the intracellular degradative pathway, Raji cells 
(1 x 10
7 
cells/mi) were pre-incubated at 37°C in the presence or 
absence of 0,1 mmol/i chloroquine diphosphate for 30 min . 125I_Insu_ 
lin (0,6 ng/mi) was then added to the incubation medium and after 
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various time intervals, the cells were centrifuged at 200 g for 5 
min and washed with HBB. After recentrifugation the cell-associated 
radioactivity was determined. Non-specific binding defined as insu-
lin binding in the presence of 10
5 
ng/mi unlabelled insulin was 
determined in both the presence and absence of chloroquine treat-
ment and subtracted from total binding. 
This experimental procedure was repeated at 15°C in the presence or 
absence of 1 mmol/i chloroquine to assess the effect of temperature 
and an increased chloroquine concentration on lysosomal degradation 
of insulin. 
5.5.4 Results 
Pre-incubation of Raji cells at 37°C with 0,1 mmol/i chloroquine 
(Fig. 5~5.a) had no significant effect on cell-associated radio-
activity. In both the control cells and cells pre-incubated with 
chloroquine, the maximum specific binding was about 2% at 60 min 
and remained at this level for a further 60 min. 
Decreasing the temperature to 15°C resulted in an overall increase 
in insulin binding (Fig. 5.5b), although a ten-fold increase in 
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Fig. 5.5 (a) Determination of lysosomal degradation of insulin 
at 37 o C. Raji cells were pre-incubated with 0,1 
mmol/l chloroquine and the amount of 
cell-associated radioactivity was determined after 






















Fig. 5.5 (b) Determination of lysosomal degradation of insulin 
at 150 C. The cells were incubated with an 
increased concentration of chloroquine (lmmol/l). 
All values represent duplicate determinations. 
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5.6 DISCUSSION 
These studies have shown that in Raji cells incubated at 37°C, most 
of the insulin was degraded by extracellular proteases in the cell-
free medium. The presence of these proteases in the medium could be 
ther€sult of either cell death or cell surface enzymes which were 
released by the cells into the medium (Roth et al., 1985). By con-
trast, at 15°C cellular degradation of insulin was increased com-
pared to extracellular degradation. It was previously shown (sec-
tion 2.6.6), that the amount of insulin bound to the receptor al-
most doubled at 15°C as compared to 37°C. It therefore seems likely 
that the increase in cellular insulin degradation seen at 15°C was 
a result of increased insulin binding to the receptor which, in turn, 
suggests a receptor-mediated degradative pathway for insulin. 
Further evidence for this mechanism was demonstrated by the de-
creased degradation of radiolabelled insulin in the presence of 
increasing concentrations of unlabelled hormone. The finding that 
125 I-glucagon degradation was not affected by the addition of unla-
belled insulin to the medium is clear evidence that insulin degra-
dation is closely related to insulin receptor binding. 
Gel filtration of acid extractable cell surface bound 125I-insulin 
revealed that only about a third of the radioactivity measured was 
in the form of intact insulin; the remainder of the radioactivity 
was eluted after the total column volume indicating that most of 
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the radioactivity on the cell surface was in the form of free amino 
acids. This evidence suggests that insulin bound to the cell mem-
brane was degraded by a specific cell surface enzyme or enzymes. 
Such a phenomenon has previously been demonstrated by Yokono et aZ. 
(1982) on the cell membrane of IM-9 lymphocytes. 
The chromatography pattern of the intracellular extract showed a 
small proportion of internalised radioactivity which was associated 
with the Vo. This fraction could represent 125 I-insulin-receptor 
complex which had been internalised or insulin associated with sub-
cellular organelles. The second peak constituted about 1/6th of the 
cell-associated radioactivity: the material eluted with the same 
volume as intact insulin and it was precipitated by 25% TCA. 
Most of the radioactivity was eluted after the total volume had 
passed through the column. Its solubility in TCA and retention by 
the column suggest that the radioactivity was associated with free 
amino acids. A reasonable conclusion from these results would be 
that the intracellular radioactivity was associated with intact 
insulin and also degradation products of insulin which were smaller 
than oligopeptides. 
In Chapter 4, it was shown that insulin was internalised by the 
cell via a receptor-mediated mechanism. It would seem reasonable to 
assume that internalised insulin is the only source of intracellu-
lar intact insulin and degradation products. However, in the Raji 
cells, internalised insulin did not appear to be degraded in the 
lysosomes as evidenced by the inability of chloroquine to inhibit 
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insulin degradation. 
At present, therefore, it is not clear whether only intact insulin 
is internalised or whether cell surface degraded insulin is also 
internalised by endocytosis. If the latter occurs, then the degra-
ded insulin within the cell might be the result of cell surface 
proteases. This possibility has been suggested by Yaso et aL. (1987) 
from studies on insulin degradation in Bri-7 cultured lymphocytes. 
On the other hand, an alternative degradative pathway might exist 
within the cell. Indeed Goldstein & Livingston (1981) have sugges-
ted that in adipocytes insulin is degraded mainly by neutral cyto-
solic proteases and not by lysosomal proteases. 
In summary, insulin appears to be degraded at the cell surface by a 
specific protease. However, unlike the IM-9 lymphocytes (Sonne & 
Gliemann, 1980) and RPMI-1788 cultured lymphocytes (Maegawa et aL., 
1983), the Raji cells have a receptor-mediated pathway for intra-
cellular degradation. As the internalised insulin is not degraded 
in the lysosomes, the insulin degradation products within the cell 
could either be a result of endocytosis of cell surface degraded 
insulin or degradation by neutral cytosolic proteases. 
CHAPTER 6 
IDENTIFICATION OF THE INSULIN BINDING SITE 
ON THE RAJI INSULIN RECEPTOR 
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"With accurate experirrent and observation to work upon~ 
ilJl1gination becomes the architect of physicaL theory." 
-TYNDALL 
6.1 INTRODUCTION 
Two major aspects of insulin-receptor interactions have been de-
cribed in previous chapters. Firstly, in Chapters 2 and 3, it was 
shown that the kinetics of insulin binding to the receptor in Raji 
cells were similar to published binding data for insulin target 
cells. Secondly, it was found that the receptor on the Raji cells 
functions normally, although the site of insulin degradation was 
different in these cells compared to adipocytes (Chapters 4 and 5). 
On this evidence it seems reasonable to assume that the virus-
induced receptors on B-Iymphocytes are indeed kinetically and func-
tionally identical to target tissue insulin receptors. However, the 
assumption will be measurably strengthened if it can be shown that 
the receptor is structurally similar to target tissue receptors. 
In this chapter, some evidence of the structural components of Raji 
cell insulin receptors is presented. 
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6.2 STRUCTURAL COMPONENTS OF THE RAJI CELL INSULIN RECEPTORS 
In section 1.5 the structure of the insulin receptor was discussed. 
The evidence for the structure is based on covalently linking label-
led insulin to the receptor components using a bifunctional cross-
linking agent, followed by sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SOS-PAGE). Visualisation of the electrophore-
tic components is achieved by exposure to a sensitive photographic 
plate. 
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6.2.1 Principle of Crosslinking of I -Insulin to Insulin 
Receptors 
The bifunctional crosslinking agent, disuccinimidyl suberate (DSS) 
can be used to covalently link two protein molecules which are 
closely bound. This reaction results in an amide bond between DSS 
and the E-amino groups of the basic amino acids in the two protein 
molecules (Fig. 6.1). Addition of Tris-EDTA prevents further cross-
linking, as excess DSS reacts with the primary amines on the Tris 
molecule. Optimum conditions for crosslinking 125I-insulin to the 
receptor on intact cells have previously been described by Pilch & 
Czech (1980). 
6.2.2 Materials 
Oisuccinimidyl suberate was obtained from Pierce Chemical Company 
and dimethyl sulphoxide (DMSO) from Merck Chemicals. 
The incubation buffer was Hepes binding buffer (HBB), described in 
124 
o 0 





15°C for 15 min. 
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1251 INSULIN - NH2' C - (CH2)2-C -N-Q-C-(CH2)6"C-Q-N-C-(CH2)2"C-NHfRECEPTOR 
( 125I-insulin crosslinked to the membrane receptor ). 
Fig. 6.1 crosslinking reaction between disuccinimidyl suberate 
and the ~-amino groups of basic amino acids on the 
receptor molecule and the insulin molecule . 
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ctl"on 2 2 3 1 Hepes binding buffer without BSA was used for the se . . . . 
incubation with DSS. 
Buffer containing 10 mmol/i Tris-HCI and 1 mmol/i EOTA pH 7,4 was 
used to stop the reaction. 
Raji cells were used during stationary phase and washed as pre-
viously described in section 2.2.3. 
The SOS-PAGE reducing application buffer contained sodium phosphate 
buffer (10 mmol/Q; pH 7,0), SOS (2%), glycerol (10%), dithiothrei-
tol (OTT) (100 mmol/i) and bromophenol blue (0,001%) . The non-
reducing application buffer was the same, but OTT was omitted. 
Solubilising buffer (pH 7,4) contained 50 mmol/i HEPES, 10 mmol/i 
MgS04 , 1% Triton x-100, 2 mmol/Q phenylmethylsulphonyl fluoride 
(PMSF) and 1000 U/mi aprotinin. 
6.2.3 Procedure 
125 
6.2.3.1 I-Insulin Crosslinked to Raji Cells in the Presence or 
Absence of Unlabelled Insulin 
Cell s were incubated (10 
8 125 
cells/2 ,5 mi) in HBB with I-insulin 
(3 X 10-
10 
mol/i) in the presence or absence of unlabelled insulin 
- 5 
(1 x 10 mol/i). Incubation was carried out at 15°C for 120 min 
after which ice-cold HBB (10 mi) without albumin was added to the 
incubation mixture. The cells were then pelleted by centrifugation 
at 200 g for 10 min at 4°C. The supernatant was discarded and 
cells were resuspended in HBB without albumin (1 mi) at 15°C . 
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Oisuccinimidyl suberate dissolved in OMSO was added to the cell 
suspension to give a final concentration of 0,5 mmol/R. After incu-
bation at 15°C for 15 min, the crosslinking reaction was stopped 
by addition of 4 mR of Tris-HCI buffer. Cells were incubated for a 
further 5 min and then centrifuged at 200 g far 10 min at 4°C. The 
cell pellet was dissolved in 250 ~R of solubilising buffer for 1 hr 
at room temperature. The supernatant was partially clarified by 
centrifugation in a Beckman microfuge (8740g) for 10 min at 4°C. 
After centrifugation, an equal volume of reducing SOS-PAGE applica-
tion buffer was added and the solution was boiled for 3 min. Elec-
trophoresis of these samples was carried out using a discontinuous 
buffer system (Laemmli , 1970) with a 4% stacking gel and a 7,5% 
resolving gel. 
6.2.3.2 Determination of 12~-Insulin Crosslinked to Raji Cells 
using Non-Reducing Conditions 
In this experiment the procedure was the same as in section 
6.2.3.1. However, in the final step solubilised cells were added 
to 250 ~R of non-reducing SOS-PAGE application buffer . The samples 
were then subjected to SOS-PAGE using a 4% stacking gel and a 5% 
resolving gel. 
6.2.3.3 Crosslinking 125I-Insulin to Raji Cells in the Presence 
of Unlabelled IGF-I or Insulin 
In section 1.3.1.2 it was mentioned that the structure of the type 
I IGF receptor and the insulin receptor is identical. By definition 
the insulin receptor is the molecule which has a greater affinity 
for insulin. Therefore crosslinking 125I-insulin to the receptor in 
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the presence of unlabelled IGF-I should not decrease the intensity 
of the insulin receptor band. 
Raji cells were incubated (10 8 /2,5 mil in HBB containing 125 1_ 
insulin (8 x 10- 10 mol/l) in the presence of unlabelled IGF-I 
(1 x 10-7 mol/l), or unlabelled insulin (1 x 10-7 mol/l),or in the 
absence of unlabelled peptide. The crosslinking procedure was fol-
lowed as described in section 6.2.3.1. 
SDS-PAGB OF THB CROSSLINKED 
125 
I-INSULIN-RBCBPTOR COMPLEX 
To determine the molecular weight of the crosslinked 12~I-insulin-
receptor complex, the sample was subjected to SOS-PAGE using a dis-
cont i nuous buffer system (Laemml.i , 1970). 
6.3.1 Reagents 
BIS-Acrylamide: 






0,1 mmol/l Tris-P04 
0,2% SOS 
4 mmol/l EOTA 
pH 6, 7 
Resolving Gel Buffer: 0,75 mmol/l Tris-HCI 
0,2% SOS 
4 mmol/l EDTA 
pH 8,9 
TEMEO: N, N, N, N Tetramethylethylenediamine 
Catalyst: 4% Ammonium Persulphate 
Electrophoresis Buffer: 50 mmol/1 Tris 
380 mmol/1 Glycine 
0,1% SDS 
Glycerol 
2 mmo 1/ 1 EDTA 
pH 8,3 
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Gel Apparatus: The Protean Dual Slab Cell was supplied by 
Bio-Rad. 
GelBond was obtained from FMC Corporation. 
14C-Molecular Weight Standards: 












Unlabelled Molecular Weight Standards: 
Unlabelled protein standards with the same molecular weight 
range were also used (Bio-Rad, USA) 
Autoradiography: Hyperfilm-MP was obtained from Amersham, UK 
Casette: A cassette with intensifying screens was used to 
store the film during exposure to the dried gel 
(Kodak, USA). 
6.3.2 Procedure 
6.3.2.1 Casting Discontinuous Gels 
Discontinuous gels consist of a resolving gel (7,5% or 5%) and a 
stacking gel (4%). Monomer solutions for the two gels were made up 
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as shown in Table 6.1. After addition of the catalyst, the resol-
ving gel was poured between the glass plate sandwich until the 
level of the gel was 3 cm from the top of the plate. Using a 
syringe, water was immediately overlayed on the resolving gel to 
give a smooth interface after polymerisation. After 30 min, the 
water was poured off and the comb was placed between the plates. 
The stacking gel monomer solution was then poured to about 1 cm 
from the top of the plates and the comb pushed down. Polymerisation 
of the stacking gel occurred after about 30 min. 
6.3.2.2 Sample Application 
After removal of the comb from the gel, each well was filled with 
electrophoresis buffer. A Hamilton syringe was used to underlay the 
sample and the molecular weight standards into individual wells. 
6.3.2.3 Running the Gel 
The glass plate assembly was placed in the Protean buffer chamber 
containing electrophoresis buffer. The water cooling system was 
turned on and the apparatus attached to the power supply. Samples 
were run at constant current (7,5 mA) until the dye front (incorpo-
rated in the application buffer) reached the end of the gel. 
6.3.2.4 Autoradiography 
After removing the gel which was attached to gelbond, it was clip-
ped to a glass plate to prevent the edges from curling over and 
allowed to dry overnight at room temperature. The dried gel was 
then placed in the cassette between the film and the intensifying 
screen. Cassettes were stored at -70°C for 6-8 weeks. 
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Table 6.1 Monomer Solutions for Discontinuous Gel Electrophoresis 







(added after solutions 





2 min) 150 jj) i 
5% Resolving 7,5% RESOLVING GEL 
gel 
7 mi 7,5 mi 
15 mi 15 mi 
6 mi 3 mi 
13 mi 4,3 mi 
20 ~i 20 ~i 
300 ~ i 300 ~ i 
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6.3.2.5 Developing and Fixing 
Films were developed manually according to the recommendations of 
the manufacturer. 
6.4 RESULTS 
6.4.1 Affinity Crosslinked 125I_Insulin in the Presence and 
Absence of Unlabelled Insulin using Reducing Conditions 
An autoradiographof 12)-insulin covalently linked to the membrane 
receptor is shown in Fig. 6.2. Tracks A and C contain the same 
crosslinked material in the absence of excess unlabelled insulin 
whereas, tracks Band D consist of similar material in the presence 
of excess unlabelled hormone (10~mol/R). The 14C-Iabelled molecular 
weight standards were run in track E. Unlabelled high molecular 
weight protein standards were run in track F. 
A single band with an apparent molecular weight of 130 kD is seen 
. 
in tracks A and C. In both tracks there are bands at the applica-
tion pOints and at the interface of the two gels, suggesting large 
molecular weight material which cannot enter the gels. 
In the presence of excess unlabelled insulin (tracks B and D) the 
130 kD band is absent. In addition, the high molecular weight bands 
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· f 125 . ·1 • 1 tl An autorad1ograph 0 I-1nsu 1n covaen y 
cross-lirtked to the insulin receptor on Raji cells. 
l25r-insulin (3 x 10-10 mol/l) was bound to Raji 
cells in the absence (A, C) or presence (B, D) of 
unlabelled insulin. The hormone-receptor complex was 
then covalently cross-linked using D.S.S., 
solubilised and reduced in the electrophoresis 
application buffer. Samples were subjected to 
SDS-PAGE on 7,5% gel and finally autoradiographed. 
Molecular weight standards are indicated on the left 
of the autoradiograph. 
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6.4.2 u5I-Insulin Crosslinked to the Re,ceptor under Non-Reducing 
Condi tions 
Using non-reduc~ng conditions a single, large molecular weight band 
of about 300 - 350 kD was observed (Fig. 6.3, track A). Once again 
this band was not observed in the presence of excess unlabelled 
insulin (track B). 
There was :also some evidence of large molecular weight products in 
track A, which have not entered the resolving gel. 
6.4.3 Crosslinked 125I-Insulin in the Presence of IGF I or 
Insulin 
In the presence of unlabelled IGF-I three distinct bands\l.ere appa-
rent (Fig. 6.4). These bands had: approximate molecular weights of 
130 kD, 105 kD and 66 kD (track C). 
Simi larly, all three bandswere~ observed in the absence of excess 
unlabelled insulin (track A). By contrast, only traces of the 105 
_7 
kD and 66 kD bands ~re observed in the presence of 10 mol/Q unla-
belled insulin (track B). The concentration of l2sI-insulin was 
slightly increased in this experiment resulting in these low mole-
cular weight bands. 
In all three experiments there was a dark band at the interface of 











12SI-insulin covalently cross-linked to the membrane 
receptor and subjected to SOS-PAGE under non-reducing 
conditions. Radiolabelled insulin was cross-linked as 
described in fig. 6.2. However, in this case, the 
sample was not reduced and SDS-PAGE was carried out 
on a 5% gel. Material in track (A) was cross-linked 
in the absence of unlabelled insulin and track (B) 













Cross-linked 125I-insulin in the presence of 
unlabelled IGF-I and insulin. The cross-linking 
procedure was carried out as described in section 
6.2.3.3 with subsequent SOS-PAGE of reduced samples. 
The autoradiograph shows radiolabelled insulin 
crosslinked in the presence of 1 x 10-7 molll IGF-I 
(C) and 1 x 10-7 molll insulin (B), and in the 
absence of unlabelled peptide (A). Molecular weight 
standards are shown on the left hand side. 
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6.5 DISCUSSION 
Covalently linking 125I_insulin to the receptor with subsequent re-
duction, SDS-PAGE and autoradiography identifie~ a radiolabelled 
molecule with a molecular weight of about 130 kD. As this was the 
major species crosslinked to 125I_insulin, these results suggest 
that the insulin binding site is found on this subunit. The large 
molecular weight species which appeared to bind insulin might be 
intact receptors, which probably result from partial purification 
of the solubilised preparation. Addition of unlabelled insulin 
during the hormone binding and crosslinking procedure, resulted in 
the loss of both bands which further supports the suggestion that 
these bands represent specific insulin binding sites. 
Using a non-reducing sample application buffer showed that radio-
labelled insulin binds to a high molecular weight (M.Wt) species 
with an apparent M.Wt of 300 kD. In this case the 130 kD binding 
site was absent. From the findings it is clear that the low mole-
cular weight binding site is a subunit of the insulin receptor, and 
in its native form the receptor exists as a disulphide-linked 
complex. 
As discussed in section 1.5.2, previous studies on fat cell and 
liver membranes have shown that insulin binds to an a subunit which 
has a M.Wt of about 130 kD (Pilch & Czech, 1980). The native recep-
tor complex has an apparent M.Wt of 300 kD and it is composed of 
two a and a-subunits which are linked by disulphide bonds (Czech, 
1985). The present study ~howed that Raji cells have an insulin 
receptor which has the same molecular structure as receptors on 
target cell membranes. 
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In section 1.3.2.1 the cross-reactivity between insulin and IGF-I 
was discussed in detail. It is now apparent that membrane receptors 
for the two peptides have very s imilar structures (Massague & Czech 
1982). In the present study, 10-7 mol/£ unlabelled IGF-I did not 
affect the intensity of the 130 kD species which binds insulin. By 
contrast, the same concentration of unlabelled insulin (10-7 mol/i) 
resulted in complete loss of the a subunit. This indicates that the 
Raji cells have a high affinity binding site which binds insulin 
but does not bind IGF-I. 
The low molecular weight bands 105 kD and 66 kD appeared to be low 
affinity insulin binding s i tes which were not entirely displaced by 
10~ mol/i of unlabelled insulin. Similar findings have been repor-
ted on fat cell and liver membranes (Pilch & Czech, 1980). However, 
the physiological relevance of these binding sites has not been 
described. 
Affinity crosslinking of 125I_insulin to the membrane receptor on 
Raji cells has shown that the a subunit has a M.Wt of 130 kD, ' is 
specific and has a high affinity for insulin. In addition, the 
molecular structure of the intact receptor is similar to insulin 
receptors on classical target tissue. 
CHAPTER 7 
CHARACTERISTICS OF TYPE I IGF RECEPTORS AND THE METABOLIC 
RESPONSE TO IGF~I AND INSULIN STIMULATION 
OF THE RAJI CELLS 
Among natural systems and phenomena~ 
resemblances occur in great numbers. 
-INGLE~ 1968 
? 1 INTRODUCTION 
138 
In the previous chapters, the kinetics of insulin binding to its 
receptor, as well as the function and structure of this receptor 
were studied in detail. It was concluded that the E-B virus did 
indeed induce insulin receptors which had all the properties des-
cribed for receptors in target organs. 
However, as discussed in section 1.3.1.2, there is some cross-
reactivity between insulin and the type I IGF-receptor and between 
IGF-I and the insulin receptor. Because insulin, IGF-I and IGF-II 
can produce the same metabolic effects at appropriate concentra-
tions and, because many cell types possess combinations of these 
three receptors (Czech 1982), it has been difficult to assess which 
receptor is mediating a specific response. 
The purpose of this chapter is the determination of the relative 
IGF and insulin receptor numbers and the biological dose-response 
of Raji cells to respective stimulation by insulin and IGF-I. 
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7.2 STEADY~STATE BINDING OF 125I _IGF I TO RAJI CELLS 
In section 2.4.6, it was shown that steady-state binding of the 
insulin to its receptor was dependent on time. A similar study was 
carried out with 12~_IGF I to determine the optimum time for steady 
-state binding to the type I IGF receptor at 15°C. 
7.2.1 Materials 
(3_[ 125 1] iodotyrosyl) Insulin-like growth factor I [ Thr5..9 ](speci-
fic activity - 2000 Ci/mmol) and unlabelled growth factor were sup-
plied by Amersham International, UK. 
Details of 125I_insulin and unlabelled insulin were previously given 
in section 2.2.1. 
Hepes binding buffer (HBB) pH 8 (section 2.2.3.1) was used through-
out in binding assays. 
Raji cells were grown until the early stationary phase of growth as 
described in section 2.4.1. Immediately before use, the cells were 
washed three times with HBB and resuspended at a concentration of 
about 1 x 10 7 cells/mi. 
7.2.2 Procedure 
Portions (400 ~i) of the cell suspension were added to test tubes 
containing 2,5 x 10- 11 mol/£ 125 I_IGF I (50 ~ £) in the presence or 
absence of 4 x 10-
7 
mol/i of unlabelled IGF I (50 ~). The incuba-
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tion mixture was maintained at 15°C. After 10 min and then at 30 
min intervals, 200 pi portions were removed and layered on to 200-
~l ice cold HBB in microfug~ tubes. The tubes were centrifuged 
(8740 g ), the supernatant was discarded and the cell pellet was 
counted in a Berthold multi-head gamma counter. 
The remaining 100 p I from each tube were pooled and 200 p I portions 
were counted to give total counts per minute (cpm). Results were 
expressed as a percentage of total cpm. Non-specific binding (NSB) 
was taken as the percentage 125I_IGF I bound in the presence of 4 x 
_7 
10 mol/l unlabelled IGF-I. Specific binding to the type I IGF 
receptor was determined by subtracting NSB from total bound. 
7.2.3 Results 
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A plot of bound I-IGF I versus time is shown in Fig. 7.1. Steady-
state binding to type I IGF receptors was achieved after 120 min at 
15°C and this level of binding was maintained for 180 min. ' 
Maximum binding ranged between 3 and 3,5% of total radioactivity, 
whereas NSBwas about 2%. As a result specific binding of 125I_IGF I 
to the Raji cells was only 1-2% of total radioactivity. 
?:3 COMPETITIVE BINDING OF IGF-I AND INSULIN TO RAJI CELLS 
The presence of specific membrane receptors for IGF-I was investi-
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steady state binding of 125I_IGF_I to Raji cells was 
determined by incubating radiolabelled peptide with 
cells in the presence or absence of unlabelled IGF-I. 
Specific binding was determined by subtracting NSB 
from total binding. All measurements were done in 
duplicate. 
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increasing concentrations of unlabelled IGF-I and insulin. The ra-
tionale for this competitive binding assay was considered in sec-
t i on 1.4. 1 . 
7.3.1 Procedure 
Cells were washed and resuspended in HBB as previously described in 
section 7.2.1. Portions (40011 f) of these cells were incubated at 
. 125 
15°C until steady state was reached (120 min) with 50 ~d I-IGF I 
(2,5 x 10- 11 mol/n and 50 llf of buffer containing increasing con-
centrations of unlabelled IGF-I (10-11 - 10-6 mol/f) or insulin 
(10- 11 - 10-5 mol/f). Maximum binding was determined by incubating 
cells with 125I_IGF I in the absence of unlabell~d peptide. 
In a parallel study 121-insulin (3 x 10~lmol/f) was added to 40011 f 
of the same cell suspension in the presence of the same increasing 
concentrations of unlabelled IGF-I and insulin. 
After incubation, duplicate portions (200 llf) were removed and lay-
ered on to 200 llf of ice cold HB8. These samples were then centri-
fuged in a Beckman microfuge. The supernatant was removed and the 
cell pellet was counted. 
Results were calculated as previously detailed in section 2.2.4. 
However, in these experiments non-specific counts were not subtrac-
ted from total binding, because the amount of radiolabelled peptide 
bound in the presence of excess unlabelled peptide is an important 




7.3.2.1 Competitive Binding for 125I_insLilin 
Competitive binding between 125I_insulin and unlabelled insulin and 
IGF-I, is shown in figure 7.2(a). Ihcreasing concentrations of unla-
belled insulin in the assay mixture resulted in a progressive de-
crease in the amount of 125I_insulin bound to the cells. About 33% 
of radiolabelled insulin remained bound in the presence of excess 
insulin (10- 5 mol/Q). 
By comparison, low concentrations of IGF-I (10-11 - 10-
8 
mol/Q) did 
not compete with bound radiolabelled insulin . . However, nearly 50% 
of bound 125I-insulin was displaced by unlabelled IGF-I in the con-
-8 -6 
centration range 10 to 10 mol/t. Approximately 50% of 125I_insu_ 
lin remained bound to the cells in the presence of 1O- 6 mol/Q IGF-I. 
In both assays, maximum 125I-insulin bound in the absence of unla-
belled peptide gave a mean value of 13,53 * 0,18% of total radio-
activity added to the incubation mixture. Non-specific binding in 
the presence of excess unlabelled insulin and IGF-I was 4,5% and 
7%, respectively. 
The concentration of insulin which caused half-maximal displacement 
of bound J..~5I-insulin (Ir~o) was in the region of 3 x 1O- 10 mol/Q, 
whereas the same effect was induced by -7 X 10 . mol/Q unlabelled 
IGF-I (Table 7.1). Thus, the ratio between the competitive poten-













Fig. 7.2 (a) 
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t ' t' f 125 , l' d' . Cornpe ~ ~on curve 0 I-~nsu ~n an ~ncreaslng 
concentrations of unlabelled insulin and IGF-I. 
Radiolabelled insulin (3XIO-11 mol/l) was 
incubated with increasing concentrations (10- 11 
-10-5 mol/l) of unlabelled insulin and IGF-I for 
120min at 1Soc. Each point is the mean and S.D, 
of two experiments. Prior to use cells were 
grown in RPMI abd 10% FeS. 
145 
Table 7.1 Insulin and IFG-I Concentrations causing Half-maximal 
Displacement of 125I-insulin or 125I_IFG_1 (ID5~ 
Rajicells grown in 
RPMI 1640 and 10% FCS 
Displacement of l25 I-insulin 
Displacement of 125I_IGF_1 
Raji cells grown in SFM 
Displacement of 125 I-insulin 




3 x 10 
augments binding 
-10 
4 x 10 
IGF-1 
(mol/i) 




7.3.2.2 Competitive Binding for 125I_IGF I 
Binding of 12sI_IGF I to Raji cells grown in 10% FCS, is shown in 
, 
Figure 7.2 (b). Unlabelled IGF-I in the range 
-11 -9 
10 - 10 mol/i 
increased binding of labelled IGF-I by about 20% with a peak at 2 x 
10-10 mol/i. Increasing the concentration of unlabelled IGF-I by one 
order of magn i tude produced an overa 11 decrease of 40% inbound 1 a-
belled peptide. A further increase in the concentration of IGF-I 
-8 
(10- 8 _ 10-6 mol/i) resulted in a second peak at 5 x 10 mol/i, 
which represented a 15% increase in 12s I_IGF I binding. In the pre~ 
sence of 10-6 mol/i unlabelled IGF-I nearly 70% of the radiolabel-
led peptide was still bound to the cells. 
Unlabelled insulin had a similar effect on radiolabelled IGF-I bin-
ding to the Raji cells. However, the initial increase in 12sI_IGF I 
binding in the range 10- 11 _ 10- 9 mol/i unlabelled insulin was 
slightly lower than that induced by a similar concentration of un-
labelled IGF-I. In addition, both peaks occurred at insulin concen-
trations ten-fold higher than unlabelled IGF-I. 
_' 5 
In the presence of a large excess of unlabelled insulin (10 mol/i 
approximately 75% of 125I_IGF I remained bound to the cells. 
The total amount of 125 I_IGF I bound in the absence of unlabelled 
peptide in both assays gave a mean value of 5,25 ± 0,15% and this 
was considered maximal. Non-specific binding of labelled peptide 
was 3,5% in the presence of excess IGF-I (10- 6 mol/i) and 4% for 


















Fig. 7.2 (b) 
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18 108 107 165 
Peptide (molll) 
competition curve of 125I_IGF_I and increasing 
concentrations of unlabelled IGF-I and insulin. 
125I_IGF_I (2,5 x 10-11 mol/I) was incubated 
with unlabelled IGF-Iand insulin in the range 
(10-11_10- 5 mol/I) until steady state at 15 0 c. 
Individual points represent the mean and one SD 
of duplicate assays. Cells were grown in RPMI 
and 10% FCS. 
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7.3.2.3 Analysis of Binding Data Using the LIGAND Programme 
Analysis of insulin binding data using the LIGAND programme was 
discussed in detail in section 3.2.1.2. It was found that the Raji 
cells have two binding sites; a high affinity receptor (Kd 2 x 
10_ 10 mol/i) and a low affinity receptor (K d 
-7 
2,27 x 10 mol/i). 
125I_IGF I binding data does not fit either the one site binding 
model or the two site binding model in the LIGAND Programme. 
7.3.3 Discussion 
From the 125I-insulin competition curve it is apparent that physio-
logical concentrations of insulin displaced the labelled ligand, 
whereas IGF-I only achieved displacement at concentrations three 
orders of magnitude greater than insulin. Half-maximal displacement 
of 12~-insulin (Table 7.1), showed that insulin was 300 times more 
potent than IGF-I in competing for this particular binding site. 
Thus, it would appear that this cell-line has an insulin receptor 
which binds insulin with a high affinity, but it also has the abi-
lity to bind IGF-I at much higher concentrations. As the 10: for 50 
unlabelled insulin and the high affinity Kd, determined by the 
LIGAND programme have very similar concentrations, the binding site 
with the highest affinity for insulin is clearly the insulin recep-
tor. 
The 125 I_IGF I competition curve for Raji cells grown in 10% FCS 
showed that low concentrations of unlabelled IGF-I and insulin did 
not compete for 12~_IGF I binding, but rather augmented it. Similar 
findings have been demonstrated in adipocytes, where physiological 
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concentrations of insulin were shown to increase binding of label-
led IGF-I and IGF-II (Zapf et a1., 1978). More recent studies have 
indicated that when insulin bound to the insulin feceptor,the number 
of IGF-II receptors were increased by inducing a rapid redistribu-
tion of type II IGF receptors cycling between an intracellular pool 
of receptors and the plasma membrane (Wardzala et aL, 1984). 
As mentioned in section 1.3.3.1, IGF-I cross-reacts with the type 
II receptor. The increase in I25 I_IGF I binding to Raji cells which 
was induced by insulin may well have been the result of IGF I bin-
ding to the type II IGF receptor. However, this finding does not 
explain the increase in radiolabelled IGF-I binding in the presence 
of similar low concentrations of unlabelled IGF-I. 
In the Raji cells, it was shown that IGF-I only competes for insu~ 
lin binding sites at concentrations greater than 10- 8 mol/i and, 
therefore, it is unlikely that this increase in 125I_IGF I binding 
is mediated by IGF-I action on the insulin receptor. In fact, lower 
concentrations of IGF-I were more effective than insulin in augmen-
ting 125I_IGF I binding to these cells. Because IGF-I does not 
normally upregulate type II IGF receptors (Rechler & Nissley, 1985) 
the implication is that the receptor which bound labelled IGF-I is 
not a true type II receptor specifically controlled by insulin 
action on the insulin receptor. 
The marked decrease in 1251_IGF I binding fn the presence of 10-9 _ 
10-.
8 mol/i unlabelled IGF-I therefore suggests that this growth fac-
tor binds to the same receptor it has induced. Insulin was slightly 
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less effective than IGF-I in competing for the same binding site. A 
reasonable conclusion could be that IGF-I, and to a lesser extent 
insulin, induced a growth factor receptor which bound both peptides 
in the same concentration range. 
Normally, insulin does not bind to the type II IGF receptor; IGF-II 
is bound to the insulin receptor with a very low affinity (section 
1.3.1.2). 
Recently, however, Misra et al. (1986) reported an unusual growth 
factor receptor in IM-9 lymphocytes which had the same affinity for 
insulin and IGF-II, but bound IGF-I with a slightly lower affinity. 
Jonas and Harrison (1985) identified two distinct type I IGF recep-
tors in material from human placentae. There is therefore, evidence 
that receptor subtypes for IGF-I and insulin might exist. 
Raji cells would appear to have a growth factor receptor which is 
induced by IGF~I and insulin. The affinity of this receptor for 
both peptides was closely related to their stimulating effect. 
Although the insulin receptor system is known to modulate type II 
IGF receptors in adipocytes (Wardzala et al., 1984), it is not 
clear from these studies whether the growth factor receptor on Raji 
cells is an atypical type I or type II IGF receptor. Another possi-
bility is that this growth factor receptor is related to a specific 
B lymphocyte growth factor. 
The large amount of radiolabelled ligand bound in the presence of 
excess unlabelled insulin and IGF-I, is manifestly unusual. A plau-
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sLble explanation could be that 125 1_IGF I binds to two receptors, 
one of which is displaced by unlabelled IGF-I and insulin. An analo-
gous situation has been reported for 125 1_IGF II binding in the pre-
sence of excess IGF-I in human fibroblasts (Rechler et aI., 1980). 
It was found that this binding pattern was not consistent and was 
probably dependent on cell culture conditions. 
In the Raji cells it was shown that high concentrations of unlabel-
led IGF-I and insulin induced a second peak of 125I_IGF I binding 
(Fig. 7.2 b), and in the following section it will be demonstrated 
that this effect was influenced by the presence of foetal calf 
serum in the culture medium. 
?4 COMPETITIVE BINDING ASSAYS FOR 125 I-IGF I AND 125 I-INSULIN ON RAJ I 
CELLS GROWN IN SERUM~FREE MEDIUM 
Serum is an important component of most growth media used in tissue 
culture. Many of the growth effects of serum have been attributed 
to the presence of appropriate growth factors, hormones and growth 
inhibitors (Zapf et al., 1981). To minimise the effects of exoge-
nous growth factors on the Raji cells, the cells were grown in RPMI 
1640 and the percentage FCS was gradually decreased from 10% to 0% 
over a period of two weeks. Competitive binding assays were then 
carried out to establish the relative numbers of insulin and type I 
IGF receptors on cells grown in serum free medium (SFM). 
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7.4.1 Procedure 
competitive binding assays between 125 I_IGF I and unlabelled IGF-I, 
and 125I-insulin and unlabelled insulin, were carried out as out-
lined in section 7.3.1. 
7.4.2 Results 
Insulin binding to Raji cells grown in SFM is shown in Figure 
7.3 (a). In the presence of increasing concentrations of unlabelled 
insulin, the amount of bound 125I-insulin gradually decreased. 
Half-maximal displacement of bound radiolabelled insulin occurred 
in the presence of 4 x 10 _10 mol/i unlabelled insulin (Table 7.1). 
The amount of l25 I-insulin bound in the absence of unlabelled hor-
mone was 13,6 ± 0,08% of total radioactivity and this was consider-
ed maximal NSB was 5,5%. 
Competitive inhibition of 125I_IGF I binding to Raji cells grown in 
SFM is shown in Figure 7.3 (b). Radiolabelled IGF-I binding to \ 
these cells was increased by approximately 15% in the presence of 
3 x 10-11 _ 10 -IO mo l!i unlabelled IGF-L After this initial increase 
at low concentrations of IGF-I, there was about a 20% decrease in 
binding at concentrations of 10-10 - 10-'1 mol/i; thereafter increased 
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Fig. 7.3 (a) 
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The insulin competition curve on cells grown in 
SFM. Raji cells were grown in SFM prior to 
measurement of insulin binding under steady 
state conditions. Binding of radiolabelled 
insulin (3X10- 11 mol/l) in the presence of 
increasing concentrations of unlabelled insulin 












Fig. 7.3 (b) 
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IGF - I 
169 1<)8 167 
Peptide molll 
competitive binding of IGF-I on Raji cells grown 
. 125 ( -11 1/1) b' d' 1n SFM. I-IGF-I 2,5xl0 rna ln lng was 
measured in the presence of increasing molar 
concentrations of unlabelled IGF-I. All 
determinAtions are the mean and one S.D. from 
duplicate samples. 
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In the presence of 10- 6 mol/Q unlabelled IGF-I, about 78% of 125 1_ 
IGF I was still bound to these cells. In this experiment the maxi-
mum amount of 125I_IGF I bound was 5,7 ± 0,45% of total radioacti-
vity and NSB was 4,6%. 
The second peak in 125I_IGF I binding which was found at 10- 8 mol/Q 
unlabelled IGF-I in cells grown in 10% FCS (Fig. 7.2 b) was absent 
in these cells. However, the amount of labelled ligand bound in the 
presence of excess unlabelled IGF-I remained high. 
7.4.3 Discussion 
Insulin competition curves on Raji cells grown in SFM and medium 
supplemented with 10% FCS were identical (Figs. 7.4 a, and 7.3 a). 
The insulin receptor on Raji cells was thus unaffected by changes 
in hormones and other factors found in serum and the conclusion may 
be drawn that in this particular cell-line the insulin receptor was 
a stable component of the cell membrane and independent of receptor 
induction by exogenous factors. The implication is that the insulin 
receptor must play an important role in regulating cell metabolism 
and replication. 
An interesting finding was that the increase in 125I_IGF I binding 
in response to low concentrations of IGF-I on cells grown in serum 
supplemented medium was retained in cells grown in SFM. In 
contrast, the same effect at higher concentrations of IGF-I was 
absent in cells grown in SFM. Presumably therefore, factors present 
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in FCS are a pre-requisite for the stimulatory effect on receptor 
induction by high concentrations of IGF-I. 
The failure to induce receptors at high concentrations of IGF-I 
would suggest that these receptors are not fundamental to Raji cell 
metabolism. 
Nevertheless, the large amount of radiolabelled ligand bound in the 
presence of excess unlabelled IGF-I was also found in cells grown 
in SFM, which suggests that the labelled ligand was bound to a 
receptor from which it is not displaced by excess unlabelled IGF-I. 
Thus, at least 70% of bound 12~_IGF I was non-specific binding. As 
mentioned earlier, Rechler et al. (1980) found that12SI-IGF II bound 
to human fibroblasts could not be completely displaced with unla-
belled IGF-I. However, this binding pattern was not reproducible 
and was probably determined by the cell culture conditions. These 
observations highlight the fact that most growth factors cross-
react with a number of related receptors and, therefore, the bind-
ing patterns are a composite of these interactions. Until all the 
relevant growth factors and their specific receptors are identified 
these binding assays will only provide a partial understanding of 
specific ligand-receptor interaction. 
In an attempt to relate ligand-receptor binding to the biological 
effect of a particular hormone o~ growth factor, dose-response 
studies were therefore undertaken. 
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7.5 INSULIN AND IGF-I STIMULATION OF ~-AMINOISOBUTYRIC ACID T~NSPORT 
IN RAJ I CELLS 
It was previously mentioned in section 1.3.1.2 that appropriate 
concentrations of IGF-I and insulin have a number of common biolo-
gical effects. These biological actions can be divided into two 
types: acute metabolic effects which involve the rapid modulation 
of membrane-transport systems or enzyme activities, and long-term 
effects such as DNA synthes i s (Zapf e't a2 ., 1981). 
The acute effects of IGF I and insulin were investigated by measu-
ring stimulation of amino acid transport across the cell membrane. 
Cellular uptake of radiolabelled ~-aminoisobutyric (AlB), an analo-
gue of alanine which is not metabolised, was measured in response 
to increasing concentrations of IGF I and insulin (Martin & Pohl, 
1979) . 
7.5.1 Materials 
~- methyl-3H -Aminoisobutyric acid with a specific activity of 33,5 
Ci/mmol was supplied by NEN Research Products, Boston, USA. Unla-
belled ~-aminoisobutyric acid was obtained from Sigma Chemical Com-
pany, St Louis, USA. 
The incubation buffer was Earle's balanced salt solution (EBSS) pH 
7,4 (5,4 mmol/.e KCI, 1,8 mmol/.e CaCI 2 , 116 mmol/.e NaCI, 1 mmol/.e 
NaHPO, 25 mmol/.e Tris-HCI and OJ 1% bovine serum albumin). OJ 1% 
Sodium dodecylsulphate (SOS) was used to solubilise the cell preci-
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pitate before addition to the scintillation cocktail . Instagel was 
purchased from Beckman Instruments, Illinoi s , USA. 
Cells were gradually adapted to serum-free medium as described in 
seciton 7.4. Twenty four hours before use the cells were incubated 
with Iscoves modified Dulbecco's medium (IMDM), supplied by Flow 
Laboratories International. 
7.5.2 Procedure 
Twenty four hours after feeding Raji cell cultures, the cells were 
harvested by centrifugation at 200 g for 5 min. The cell pellet was 
resuspended in the same volume of EBSS and incubated at 37°C for 1 
hour to facilitate the dissociation of any membrane bound hormones. 
Following incubation, cells were centrifuged at 200 q for 5min and 
resuspended in the same volume of fresh EBSS. Duplicate portions of 
cell suspensions (450 , ~1) were pipetted into test tubes which con-
tained 50 ~l of insulin or IGF-I, respectively (final concentra-
- 10 -9 -8 - 7 -6 
tions: 0, 10, 10, 10, 10, 10 mol/lYe The incubation mixtures were 
maintained at 37°C for 4 hours, after which 10 Jll of 3 H-AIB and un-
labelled AlB were added to each test tube to give a final concen-
!ration of 0;3 I1 Ci3H-AIB and 0,1 mmol/l AlB per tube, respectively. 
This was followed by a further incubation at 37°C for 25 min and 
three washes with EBSS at 4°C. The cell pellet was sOlubilised with 
500 ~ 1 of 0, 1% SDS at 3]oC. Portions (400 11 .e) were transferred to 
scintillation vials containing Instagel and counted in a Beckman LS 
1800 Spectrophotometer which had a counting efficiency of about 51%. 
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7.5.3 Calculations 
The number of disintegrations per minute (dpm), was calculated by 
dividing counts per minute (cpm) by the counting efficiency 
cpm = dpm 
efficiency. 
Uptake of AlB (nmol) was calculated using the following formula 
where 1 nCi = 2,22 x 10 3 dpm (Thach & Newburger, 1972): 
nmol AlB = no. of dpm per tube 
(2,22x1~) (SA of AlB, nCi/nmol). 
Results were expressed graphically as nmol AlB uptake per 10
8 
cells 
versus hormone concentration (mol/i). 
7.5.4 Results 
Stimulation of amino acid transport in Raji cells by increasing 
concentrations of IGF-I and insulin is shown in Fig. 7.4. The pre-
sence of increasing concentrations of insulin in the incubation 
medil~m resulted in a dose-related increase in 3H-AIB uptake (0,34 -
0,48 nmol), which reached a plateau at 10-7 mol/i insulin. IGF-I, 
on the other hand, did not stimulate 3 H-AIB transport in the Raji 
cells. 
Half-maximal stimulation of amino acid uptake by insulin was about 
-10 
































IGF - I 
Peptide concentration (mollJ) 
Insulin and IGF-I stimulation of (l - arninoisobutyric 
acid uptake in Raji cells. The effect of increasing 
molar concentrations of insulin and lGF-l on a-AlB 
transport in Raji cells was determined as described 
in section 7.5.2 . Each point is the mean and one S.D. 
of quadruplicate measurements. 
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Table 7.2 Insulin and IGF-I Concentrations Eliciting Half-maximal 
Stimulation of a-AlB Uptake and DNA Synthesis 
Concentration of Unlabelled Peptide 
Half-maximal stimulation of a-AlB uptake 










It was concluded earlier (section 7.4.3), that the insulin receptor 
plays an important role in Raji cell metabolism. Support for this 
proposal was provided by the experimental stimulation of a-AlB up-
take. Insulin stimulation of a-AlB transport was maximal at physio-
logical concentrations of insulin. Half-maximal stimulation of 
a-AlB uptake corresponded with the 1D50 of unlabelled insulin for the 
-10 -10 
insulin receptor, 5 x 10 mol/R and 3 x 10 mol/R , respectively. 
By comparison, increasing concentrations of IGF-I had no signifi-
cant effect on amino acid transport in Raji cells. These results 
support the concept that the acute metabolic actions of insulin on 
these cells are mediated via the insulin receptor. 
The longer term biological effects of 1GF-I and insulin were next 
studied, to determine whether insulin or the type I receptor media-
ted the growth response . 
7.6 MEASUREMENT OF INSULIN AND IGF-I STIMULATION OF DNA SYNTHESIS IN 
RAJI CELLS 
To assess the relative potencies of insulin and 1GF-I as stimula-
tors of cell-proliferation, cells were exposed to increasing con-
centrations of each peptide and 3H-thymidine uptake was estimated 
as a measure of cell proliferation (Rechler et aL., 1974). 
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If this biological response is mediated by ligand interaction with 
the insulin or type I IGF receptor, then the stimulatory effect 
should be reflected by receptor affinity for that ligand. 
As mentioned earlier in section 7.4, the main function of serum in 
tissue culture is to provide essential hormones and growth factors. 
The advantage of using serum-free medium (SFM), when measuring a 
proliferative response to specific growth factors, is the absence 
of unknown factors capable of blocking or facilitating cell growth . 
For this reason Iscoves modified Dulbecco's medium (IMDM), which is 
a serum~free medium, was developed specifically for these studies 
(Gersten & Cohn, 1987). These authors have shown thatIMDM optimal-




Methyl- H-Thymidine with a specific activity of 6,7 Ci/mmol was 
purchased from NEN Research Products, USA. 
Microwell plates (96 wells) were obtained from NUNC, Denmark. 
Glass fibre filters were supplied by Whatman, UK. 
Iscoves modified Dulbecco's medium was obtained from Flow Labora-
tories,UK. 
Suppliers of unlabelled insulin and IGF-I were as in section 7.2.1. 
RPMI 1640 was purchased from Flow Laboratories, UK. 
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7.6.2 Procedure 
Raji cells were grown in RPMI 1640 medium supplemented with de-
creasing amounts of FCS. Once the cells in RPMI 1640 and 1% FCS 
reached stationary growth phase, they were centrifuged at 200 g for 
5 min. The cell pellet was then resuspended in the same volume of 
IMDM without FCS. The concentration of the cells was adjusted to 
6 
1-1,3 x 10 cells/m1 and 150 11 1 of cell suspension (in sextupli-
cate) was added to each well of a 96 microwell plate. A further 
50 ~1 of IMDM containing IGF-I and insulin in the concentration 
- 12 -7 range 10 - 10 mol/1 was added to the cell suspension. Cells were 
grown for 72 hr at 37°C in a humidified 6% CO2 atmosphere as descri-
bed by Gordon et al. (1985). 
After incubation 50 ~ 1 of 3 H-Ttwmidine was added to each well to 
give a final concentration of 2 ~ Ci/m1; incubation was then conti-
nued for a further 4 hours at 37°C in 6% CO 2 and air. 
Cells were harvested onto fibreglass filter paper using a multi-
sample automatic harverster, washed with distilled water, dried and 
then dissolved in Jnstagel. Samples were counted in a Beckman LS 
1800 spectrometer with a counting efficiency· of about 47%. 
7.6.3 Results 
Results were presented as a plot of % maximal H-lhymidine uptake 
(y-axis), or cpm (opposite the y-axis), versus peptide concentra-
tion. 
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Stimulation of H-Thymidine uptake by Raji cells 72 hrs after incu-
bation with increasing concentrations of IGF-I and insulin is shown 
in Fig. 7.5. 
Insulin and IGF-I were equipotent in stimulating 3 H-Thymidine up-
take in Raji cells. Cell proliferation increased with increasing 
concentrations of both peptides and reached a peak at 10-9 mol/i. 





mol/i). By comparison, there was a slight 
drop in insulin stimulation over the same concentration range. The 
1050 values for insulin and IGF-I were very similar, 1 x 10-
11 
mol/i 
and 2 x 10- 11 mol/i, respectively (Table 7.2). 
7.6.4 Discussion 
It is well known that pharmacological doses of insulin stimulate 
cell proliferation in tissue culture (Zapf et aL, 1981). On the 
other hand, IGF-I was able to stimulate cell growth at molar con-
centrations, 50-fold lower than insulin. As discussed in section 
1.3.1.2, the type I receptor has a greater affinity for IGF-I than 
insulin. Thus, it was initially thought that both IGF-I and insulin 
stimulated cell growth by acting on the type I IGF receptor. Al-
though this hypothesis was true for human fibroblasts (King et aL., 
1980) and chick embryo fibroblasts (Rechler et aL, 1980), a number 
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stimulation of 3H-thymidine uptake with increasing 
concentrations of insulin and IGF-I. Raji cells were 
pre-incubated with increasing molar concentrations of 
insulin and IGF-I for 72 hours. After incubation, 
3H-thymidine was added to the cells and incubated for 
a further 4 hours. Cells were harvested, washed and 
the amount of 3H-thymidine incorporated in the cells 
was determined. All measurements were done in 
sextuplicate. 
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In the Raji cells, concentrations of insulin in the physiological 
range (2 x 10- 12 - 10-9 mol/.Q) induced an increase in cell prolife-
ration. These results implied that insulin action via the insulin 
receptor, stimulated cell growth. Convincing evidence that insulin 
acts as a mitogen through the insulin receptor has been reported in 
H-35 rat hepatoma cells (Koontz & Iwahashi, 1981) and F-9 terato-
carcinoma cells (Nagarajan & Anderson, 1982). 
In the Raj i ce 11 sit was apparent that, if the dose - res[X1lse curve 
for insulin had been continued with higher concentrations, it would 
probably result in a bell-shaped curve which is a typical lympho-
cyte response to mitogen stimulation (Oi Sabato et al ., 1987). 
These observations indicate that in Rajicells, physiological 
concentrations of insulin stimulate cell growth through the insulin 
receptor. 
However, the 10 50 for insulin displacement of bound
12s 1-insulin was 
ten-fold higher than the half-maximal stimulation of DNA synthesis. 
More importantly, these results have shown that 1GF-1 and insulin 
are equally potent in stimulating DNA synthesis. Equivalence in 
action may have been mediated by individual high affinity receptors 
or by a receptor which bound both ligands with the same affinity. 
Binding studies on Raji cells have established the presence of an 
atypical growth factor receptor which had a similar competitive 
binding profile for both unlabelled insulin and 1GF-1. Low concen-
trations of both hormones (10- 11 _ 10-9 mol/.Q) induced this receptor 
with which there was some cross-reactivity (section 7.3.2.2). 
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8ecause the binding profiles of insulin and IGF-I for this growth 
factor receptor were so similar, and because the mitogenic effects 
of these peptides were quantitatively identical, growth stimulation 
appeared likely to have been mediated by this induced receptor. 
If this inference is correct, physiological levels of IGF-I and in-
sulin would be capable of inducing a membrane receptor with which 
they subsequently interact with resultant stimulation of DNA syn-
thesis. 
In section 1.8 it was mentioned that Raji cells in early log phase 
produce a 8-cell growth factor (8CGF) which can induce cell repli-
cation, presumably via a 8CGF receptor (Gordon et al., 1985). These 
authors suggested that the evolution of 8-cell tumours represents a 
more efficient utilisation of BCGF or, alternatively, a growth fac-
tor-independent mechanism for autonomous growth. According to their 
model of 8-cell lymphomagenesis the Raji cells are still responsive 
to an autologous growth factor. In view of the BCGF autocrine loop 
identified in Raji cells, it is quite conceivable that this growth 
factor might induce its own receptor, bind to it and thus stimulate 
cell growth. Indeed, this mechanism of action would result in ex-
tremely efficient use of low concentrations of autologous 8CGF. 
Manifestly, the Raji cells have a highly efficient growth factor 
receptor which is induced by low levels of IGF-I and insulin. Very 
low concentrations of these peptides stimulate DNA synthesis. As 
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the mechanism of action for IGF-I and insulin in Raji cells is si-
milar to that postulated for BCGF (Gordon et a L., 1985) the two 
pathways could be the same. 
It is suggested that this atypical growth factor receptor identi-
fied on these cells is in fact a BCGF receptor which cross-reacts 
with IGF-I and insulin. 
?? CONCLUSION 
Raji cells have a high affinity receptor which is specific for 
insulin. It is not induced by insulin or any growth factor. 
In contrast, these cells have an unusual growth factor receptor 
which is induced by low concentrations of both insulin and IGF-I. 
This receptor has a relatively high affinity for IGF-I although 
about 70% of the binding to Raji cells is not displaceable, which 
suggests that IGF-I is not binding to a specific type I IGF recep-
tor. A possible explanation for the high NSB is that IGF-I, and to 
a lesser extent insulin, bind to a specific B lymphocyte growth 
factor receptor, probably the BCGF receptor. 
The acute metabolic effects of physiological concentrations of 
insulin on amino acid transport are mediated by the insulin recep-
tor, whereas IGF- I does not demonstrate this response. 
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Growth promoting effects of insulin and IGF-I do not appear to be 
mediated via their specific receptors. A more likely mechanism is 
that these peptides induce a third receptor , the BCGF receptor, 
then bind to the induced receptor and through this binding mediate 
cell proliferation. 
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SUM MAR Y 
This study has shown that the Raji cells have an insulin receptor on 
the cell membrane which is specific for insulin. Kinetic analysis of 
insulin binding data suggested the presence of two insulin binding 
sites, one of which had a high affinity for the ligand whereas the 
other had a low affinity for insulin. There was also some evidence 
of site-site interactions induced by a change in the conformation of 
the receptor. It was, therefore concluded, that the insulin receptor 
on these cells is best described by the receptor model which inclu-
des heterogeneous binding sites and negative co-operativity. 
Physiological concentrations of insulin induced downregulation of 
the membrane receptor, which suggested that the insulin receptor is 
functional. However, degradation of internalised insulin did not 
occur in the lysosomes. 
Affinity crosslinking of 125I-insulin to the membrane receptor indi-
cated the presence of a 130 kD insulin binding site and a non-
reduced receptor with a molecular weight of about 300 kD. These 
findings support the structural model proposed by Czech, 1985. 
Raji cells did not have a specific type I IGF receptor. Neverthe-
less, it was shown that low concentrations of insulin and IGF-I in-
duced a growth factor receptor and both peptides appeared to cross-
react with this receptor. 
Insulin stimulation of amino acid transport in the Raji cells was 
mediated by the insulin receptor. In contrast, stimulation of cell 
proliferation by both insulin and IGF-I was probably mediated by 
regulation of the BCGF receptor. 
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